https://kymos.com/es/news/crecimiento-del-mercado-de-cro/ 2017-09-17T09:58:39+00:00 https://kymos.com/wp-content/uploads/2021/11/cro_market_0.jpg https://kymos.com/ca/news/creixement-del-mercat-cro/ 2017-09-17T09:58:39+00:00 https://kymos.com/wp-content/uploads/2021/11/cro_market_0.jpg https://kymos.com/ko/news/cro-%ec%8b%9c%ec%9e%a5-%ec%84%b1%ec%9e%a5/ 2017-09-17T09:58:39+00:00 https://kymos.com/wp-content/uploads/2021/11/cro_market_0.jpg https://kymos.com/it/news/crescita-del-mercato-cro/ 2017-09-17T09:58:39+00:00 https://kymos.com/wp-content/uploads/2021/11/cro_market_0.jpg https://kymos.com/de/news/wachstum-des-cro-marktes/ 2017-09-17T09:58:39+00:00 https://kymos.com/wp-content/uploads/2021/11/cro_market_0.jpg https://kymos.com/fr/news/croissance-du-marche-des-cro/ 2017-09-17T09:58:39+00:00 https://kymos.com/wp-content/uploads/2021/11/cro_market_0.jpg https://kymos.com/es/news/metodos-bioanaliticos-adecuados-al-proposito-validacion-cientifica/ 2018-02-13T11:04:59+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioanalytical-method-validation.jpg https://kymos.com/ca/news/metodes-bioanalitics-adequats-a-lobjectiu-validacio-cientifica/ 2018-02-13T11:04:59+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioanalytical-method-validation.jpg https://kymos.com/it/news/metodi-bioanalitici-adatti-allo-scopo-validazione-scientifica/ 2018-02-13T11:04:59+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioanalytical-method-validation.jpg https://kymos.com/de/news/zweckmaessige-bioanalytische-methoden-wissenschaftliche-validierung/ 2018-02-13T11:04:59+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioanalytical-method-validation.jpg https://kymos.com/fr/news/methodes-bioanalytiques-adaptees-a-lusage-validation-scientifique/ 2018-02-13T11:04:59+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioanalytical-method-validation.jpg https://kymos.com/ko/news/%eb%aa%a9%ec%a0%81%ec%97%90-%eb%a7%9e%eb%8a%94-%ec%83%9d%eb%ac%bc-%eb%b6%84%ec%84%9d-%eb%b0%a9%eb%b2%95-%ea%b3%bc%ed%95%99%ec%a0%81-%ea%b2%80%ec%a6%9d/ 2018-02-13T11:04:59+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioanalytical-method-validation.jpg https://kymos.com/es/news/nueva-regulacion-de-cosmeticos-en-espana/ 2018-03-02T11:06:15+00:00 https://kymos.com/wp-content/uploads/2021/11/cosmetics-regulation-in-Spain.jpg https://kymos.com/ca/news/nova-regulacio-de-cosmetics-a-espanya/ 2018-03-02T11:06:15+00:00 https://kymos.com/wp-content/uploads/2021/11/cosmetics-regulation-in-Spain.jpg https://kymos.com/ko/news/%ec%8a%a4%ed%8e%98%ec%9d%b8%ec%9d%98-%ec%83%88%eb%a1%9c%ec%9a%b4-%ed%99%94%ec%9e%a5%ed%92%88-%ea%b7%9c%ec%a0%95/ 2018-03-02T11:06:15+00:00 https://kymos.com/wp-content/uploads/2021/11/cosmetics-regulation-in-Spain.jpg https://kymos.com/it/news/nuova-regolamentazione-dei-cosmetici-in-spagna/ 2018-03-02T11:06:15+00:00 https://kymos.com/wp-content/uploads/2021/11/cosmetics-regulation-in-Spain.jpg https://kymos.com/de/news/neue-kosmetikverordnung-in-spanien/ 2018-03-02T11:06:15+00:00 https://kymos.com/wp-content/uploads/2021/11/cosmetics-regulation-in-Spain.jpg https://kymos.com/fr/news/nouvelle-reglementation-sur-les-produits-cosmetiques-en-espagne/ 2018-03-02T11:06:15+00:00 https://kymos.com/wp-content/uploads/2021/11/cosmetics-regulation-in-Spain.jpg https://kymos.com/es/news/aprobacion-de-kymos-como-laboratorio-de-referencia-para-productos-biologicos-en-el-libano/ 2018-03-02T11:08:44+00:00 https://kymos.com/wp-content/uploads/2018/03/Banner_Lebanon-e1658232882595.png https://kymos.com/ca/news/aprovacio-de-kymos-com-a-laboratori-de-referencia-per-a-productes-biologics-al-liban/ 2018-03-02T11:08:44+00:00 https://kymos.com/wp-content/uploads/2018/03/Banner_Lebanon-e1658232882595.png https://kymos.com/fr/news/kymos-est-agree-comme-laboratoire-de-reference-pour-les-produits-biologiques-au-liban/ 2018-03-02T11:08:44+00:00 https://kymos.com/wp-content/uploads/2018/03/Banner_Lebanon-e1658232882595.png https://kymos.com/ko/news/%eb%a0%88%eb%b0%94%eb%85%bc-%ec%83%9d%eb%ac%bc%ed%95%99-%ec%97%b0%ea%b5%ac%ec%8b%a4-%ea%b8%b0%ec%a4%80-%ec%97%b0%ea%b5%ac%ec%86%8c%eb%a1%9c-kymos-%ec%8a%b9%ec%9d%b8/ 2018-03-02T11:08:44+00:00 https://kymos.com/wp-content/uploads/2018/03/Banner_Lebanon-e1658232882595.png https://kymos.com/it/news/kymos-approvato-come-laboratorio-di-riferimento-per-i-prodotti-biologici-in-libano/ 2018-03-02T11:08:44+00:00 https://kymos.com/wp-content/uploads/2018/03/Banner_Lebanon-e1658232882595.png https://kymos.com/de/news/kymos-wurde-als-referenzlabor-fuer-biologika-im-libanon-zugelassen/ 2018-03-02T11:08:44+00:00 https://kymos.com/wp-content/uploads/2018/03/Banner_Lebanon-e1658232882595.png https://kymos.com/fr/news/nouvelles-recommandations-de-la-fda-sur-la-validation-des-methodes-bioanalytiques/ 2018-05-25T10:14:44+00:00 https://kymos.com/wp-content/uploads/2021/11/FDA_Bioanalytical-Method-Validation.jpg https://kymos.com/es/news/nueva-guia-de-la-fda-sobre-la-validacion-de-metodos-bioanaliticos/ 2018-05-25T10:14:44+00:00 https://kymos.com/wp-content/uploads/2021/11/FDA_Bioanalytical-Method-Validation.jpg https://kymos.com/ca/news/nova-guia-de-la-fda-sobre-la-validacio-de-metodes-bioanalitics/ 2018-05-25T10:14:44+00:00 https://kymos.com/wp-content/uploads/2021/11/FDA_Bioanalytical-Method-Validation.jpg https://kymos.com/ko/news/%ec%83%9d%eb%ac%bc%eb%b6%84%ec%84%9d-%eb%b0%a9%eb%b2%95-%ea%b2%80%ec%a6%9d%ec%97%90-%eb%8c%80%ed%95%9c-%ec%83%88%eb%a1%9c%ec%9a%b4-fda-%ec%a7%80%ec%b9%a8/ 2018-05-25T10:14:44+00:00 https://kymos.com/wp-content/uploads/2021/11/FDA_Bioanalytical-Method-Validation.jpg https://kymos.com/it/news/nuove-linee-guida-della-fda-sulla-convalida-del-metodo-bioanalitico/ 2018-05-25T10:14:44+00:00 https://kymos.com/wp-content/uploads/2021/11/FDA_Bioanalytical-Method-Validation.jpg https://kymos.com/de/news/neue-fda-leitlinien-zur-validierung-bioanalytischer-methoden/ 2018-05-25T10:14:44+00:00 https://kymos.com/wp-content/uploads/2021/11/FDA_Bioanalytical-Method-Validation.jpg https://kymos.com/ko/news/%ed%97%a4%ed%8c%8c%eb%a6%b0-%ed%95%ad%ec%9d%b8%ec%9e%90-%ed%99%9c%ec%84%b1-%ea%b2%80%ec%82%ac/ 2018-07-07T11:25:50+00:00 https://kymos.com/wp-content/uploads/2021/11/Heparin-Anti-factor-Activity-Testing.jpg https://kymos.com/es/news/prueba-de-actividad-del-antifactor-de-heparina/ 2018-07-07T11:25:50+00:00 https://kymos.com/wp-content/uploads/2021/11/Heparin-Anti-factor-Activity-Testing.jpg https://kymos.com/ca/news/prova-dactivitat-antifactor-de-lheparina/ 2018-07-07T11:25:50+00:00 https://kymos.com/wp-content/uploads/2021/11/Heparin-Anti-factor-Activity-Testing.jpg https://kymos.com/it/news/test-di-attivita-antifattoriale-delleparina/ 2018-07-07T11:25:50+00:00 https://kymos.com/wp-content/uploads/2021/11/Heparin-Anti-factor-Activity-Testing.jpg https://kymos.com/de/news/heparin-anti-faktor-aktivitaetstest/ 2018-07-07T11:25:50+00:00 https://kymos.com/wp-content/uploads/2021/11/Heparin-Anti-factor-Activity-Testing.jpg https://kymos.com/fr/news/tests-dactivite-anti-facteur-de-lheparine/ 2018-07-07T11:25:50+00:00 https://kymos.com/wp-content/uploads/2021/11/Heparin-Anti-factor-Activity-Testing.jpg https://kymos.com/it/news/qualita-ed-equivalenza-dei-prodotti-topici/ 2019-04-28T11:38:43+00:00 https://kymos.com/wp-content/uploads/2019/04/hanson_franz_cells_copy_Topical-Products.jpg https://kymos.com/de/news/qualitaet-und-gleichwertigkeit-topischer-produkte/ 2019-04-28T11:38:43+00:00 https://kymos.com/wp-content/uploads/2019/04/hanson_franz_cells_copy_Topical-Products.jpg https://kymos.com/es/news/calidad-y-equivalencia-de-productos-topicos/ 2019-04-28T11:38:43+00:00 https://kymos.com/wp-content/uploads/2019/04/hanson_franz_cells_copy_Topical-Products.jpg https://kymos.com/fr/news/qualite-et-equivalence-des-produits-topiques/ 2019-04-28T11:38:43+00:00 https://kymos.com/wp-content/uploads/2019/04/hanson_franz_cells_copy_Topical-Products.jpg https://kymos.com/ko/news/%ea%b5%ad%ec%86%8c-%ec%a0%9c%ed%92%88%ec%9d%98-%ed%92%88%ec%a7%88-%eb%b0%8f-%eb%8f%99%eb%93%b1%ec%84%b1/ 2019-04-28T11:38:43+00:00 https://kymos.com/wp-content/uploads/2019/04/hanson_franz_cells_copy_Topical-Products.jpg https://kymos.com/es/news/analisis-de-proteinas-de-la-celula-huesped/ 2019-05-17T09:14:16+00:00 https://kymos.com/wp-content/uploads/2019/05/host-cell-protein-antibodies_10.32.33.jpg https://kymos.com/ko/news/%ec%88%99%ec%a3%bc-%ec%84%b8%ed%8f%ac-%eb%8b%a8%eb%b0%b1%ec%a7%88-%eb%b6%84%ec%84%9d/ 2019-05-17T09:14:16+00:00 https://kymos.com/wp-content/uploads/2019/05/host-cell-protein-antibodies_10.32.33.jpg https://kymos.com/it/news/analisi-delle-proteine-delle-cellule-ospiti/ 2019-05-17T09:14:16+00:00 https://kymos.com/wp-content/uploads/2019/05/host-cell-protein-antibodies_10.32.33.jpg https://kymos.com/de/news/analyse-der-wirtszellproteine/ 2019-05-17T09:14:16+00:00 https://kymos.com/wp-content/uploads/2019/05/host-cell-protein-antibodies_10.32.33.jpg https://kymos.com/fr/news/analyse-des-proteines-de-la-cellule-hote/ 2019-05-17T09:14:16+00:00 https://kymos.com/wp-content/uploads/2019/05/host-cell-protein-antibodies_10.32.33.jpg https://kymos.com/ca/news/analisi-de-proteines-de-cellules-hostes/ 2019-05-17T09:14:16+00:00 https://kymos.com/wp-content/uploads/2019/05/host-cell-protein-antibodies_10.32.33.jpg https://kymos.com/es/news/que-sucede-con-las-pruebas-y-la-liberacion-de-lotes-despues-del-brexit/ 2019-10-04T09:11:24+00:00 https://kymos.com/wp-content/uploads/2021/11/thumbnail_Brexit-image-Mailchimp-and-social.png https://kymos.com/fr/news/que-deviendraient-les-tests-et-la-liberation-par-lots-apres-le-brexit/ 2019-10-04T09:11:24+00:00 https://kymos.com/wp-content/uploads/2021/11/thumbnail_Brexit-image-Mailchimp-and-social.png https://kymos.com/ko/news/brexit-%ec%9d%b4%ed%9b%84-%ec%9d%bc%ea%b4%84-%ed%85%8c%ec%8a%a4%ed%8a%b8-%eb%b0%8f-%ec%9d%bc%ea%b4%84-%eb%a6%b4%eb%a6%ac%ec%8a%a4%eb%8a%94-%ec%96%b4%eb%96%bb%ea%b2%8c-%eb%90%98%eb%82%98%ec%9a%94/ 2019-10-04T09:11:24+00:00 https://kymos.com/wp-content/uploads/2021/11/thumbnail_Brexit-image-Mailchimp-and-social.png https://kymos.com/it/news/cosa-succede-ai-test-in-batch-e-al-rilascio-dei-batch-dopo-la-brexit/ 2019-10-04T09:11:24+00:00 https://kymos.com/wp-content/uploads/2021/11/thumbnail_Brexit-image-Mailchimp-and-social.png https://kymos.com/de/news/was-geschieht-nach-dem-brexit-mit-chargentests-und-chargenfreigabe/ 2019-10-04T09:11:24+00:00 https://kymos.com/wp-content/uploads/2021/11/thumbnail_Brexit-image-Mailchimp-and-social.png https://kymos.com/ca/news/que-passa-amb-les-proves-per-lots-i-lalliberament-per-lots-despres-del-brexit/ 2019-10-04T09:11:24+00:00 https://kymos.com/wp-content/uploads/2021/11/thumbnail_Brexit-image-Mailchimp-and-social.png https://kymos.com/es/news/el-dr-carles-celma-experto-en-productos-biologicos-participara-en-el-congreso-de-biosimilares-y-biologicos/ 2019-10-05T09:09:43+00:00 https://kymos.com/wp-content/uploads/2019/10/Biosimilars-Rome-with-Carles-Celma_short-e1658232281991.png https://kymos.com/ko/news/%ec%83%9d%eb%ac%bc%ed%95%99-%ec%a0%84%eb%ac%b8%ea%b0%80-carles-celma-%eb%b0%95%ec%82%ac%ea%b0%80-%eb%b0%94%ec%9d%b4%ec%98%a4%ec%8b%9c%eb%b0%80%eb%9f%ac-%eb%b0%8f-%ec%83%9d%eb%ac%bc%ed%95%99-%ec%9d%98/ 2019-10-05T09:09:43+00:00 https://kymos.com/wp-content/uploads/2019/10/Biosimilars-Rome-with-Carles-Celma_short-e1658232281991.png https://kymos.com/it/news/lesperto-di-prodotti-biologici-il-dott-carles-celma-interverra-al-congresso-sui-biosimilari-e-i-prodotti-biologici/ 2019-10-05T09:09:43+00:00 https://kymos.com/wp-content/uploads/2019/10/Biosimilars-Rome-with-Carles-Celma_short-e1658232281991.png https://kymos.com/de/news/der-biologika-experte-dr-carles-celma-wird-auf-dem-biosimilars-und-biologika-kongress-sprechen/ 2019-10-05T09:09:43+00:00 https://kymos.com/wp-content/uploads/2019/10/Biosimilars-Rome-with-Carles-Celma_short-e1658232281991.png https://kymos.com/fr/news/le-dr-carles-celma-expert-en-produits-biologiques-interviendra-au-congres-sur-les-biosimilaires-et-les-produits-biologiques/ 2019-10-05T09:09:43+00:00 https://kymos.com/wp-content/uploads/2019/10/Biosimilars-Rome-with-Carles-Celma_short-e1658232281991.png https://kymos.com/es/news/la-dra-lluisa-garcia-aconseja-sobre-como-gestionar-las-impurezas-de-n-nitrosamina-en-los-sartanes/ 2019-12-10T10:07:09+00:00 https://kymos.com/wp-content/uploads/2019/12/Nitrosamines-interview-with-Lluisa_Short-e1658232221728.png https://kymos.com/it/news/la-dott-ssa-lluisa-garcia-fornisce-consigli-su-come-gestire-le-impurita-di-n-nitrosammina-nei-sartani/ 2019-12-10T10:07:09+00:00 https://kymos.com/wp-content/uploads/2019/12/Nitrosamines-interview-with-Lluisa_Short-e1658232221728.png https://kymos.com/de/news/dr-lluisa-garcia-gibt-ratschlaege-zum-umgang-mit-n-nitrosamin-verunreinigungen-in-sartanen/ 2019-12-10T10:07:09+00:00 https://kymos.com/wp-content/uploads/2019/12/Nitrosamines-interview-with-Lluisa_Short-e1658232221728.png https://kymos.com/fr/news/le-dr-lluisa-garcia-donne-des-conseils-sur-la-gestion-des-impuretes-de-n-nitrosamines-dans-les-sartans/ 2019-12-10T10:07:09+00:00 https://kymos.com/wp-content/uploads/2019/12/Nitrosamines-interview-with-Lluisa_Short-e1658232221728.png https://kymos.com/ko/news/lluisa-garcia-%eb%b0%95%ec%82%ac%eb%8a%94-%ec%82%ac%eb%a5%b4%ed%83%84%ec%9d%98-n-%eb%8b%88%ed%8a%b8%eb%a1%9c%ec%82%ac%eb%af%bc-%eb%b6%88%ec%88%9c%eb%ac%bc%ec%9d%84-%ea%b4%80%eb%a6%ac%ed%95%98%eb%8a%94/ 2019-12-10T10:07:09+00:00 https://kymos.com/wp-content/uploads/2019/12/Nitrosamines-interview-with-Lluisa_Short-e1658232221728.png https://kymos.com/ca/news/la-dra-lluisa-garcia-assessora-sobre-com-gestionar-les-impureses-de-n-nitrosamina-en-els-sartans/ 2019-12-10T10:07:09+00:00 https://kymos.com/wp-content/uploads/2019/12/Nitrosamines-interview-with-Lluisa_Short-e1658232221728.png https://kymos.com/es/news/bioanalisis-armonizacion-experiencia-y-buenas-practicas/ 2020-02-26T10:04:29+00:00 https://kymos.com/wp-content/uploads/2021/11/Digna-Tost-Bioanalysis_Short-e1658232207238.png https://kymos.com/ko/news/%ec%83%9d%eb%ac%bc%eb%b6%84%ec%84%9d-%ec%a1%b0%ed%99%94-%ea%b2%bd%ed%97%98-%eb%b0%8f-%ec%9a%b0%ec%88%98-%ec%82%ac%eb%a1%80/ 2020-02-26T10:04:29+00:00 https://kymos.com/wp-content/uploads/2021/11/Digna-Tost-Bioanalysis_Short-e1658232207238.png https://kymos.com/it/news/bioanalisi-armonizzazione-esperienza-e-buone-pratiche/ 2020-02-26T10:04:29+00:00 https://kymos.com/wp-content/uploads/2021/11/Digna-Tost-Bioanalysis_Short-e1658232207238.png https://kymos.com/de/news/bioanalytik-harmonisierung-erfahrung-und-bewaehrte-verfahren/ 2020-02-26T10:04:29+00:00 https://kymos.com/wp-content/uploads/2021/11/Digna-Tost-Bioanalysis_Short-e1658232207238.png https://kymos.com/fr/news/bioanalyse-harmonisation-experience-et-bonnes-pratiques/ 2020-02-26T10:04:29+00:00 https://kymos.com/wp-content/uploads/2021/11/Digna-Tost-Bioanalysis_Short-e1658232207238.png https://kymos.com/ca/news/bioanalisi-harmonitzacio-experiencia-i-bones-practiques/ 2020-02-26T10:04:29+00:00 https://kymos.com/wp-content/uploads/2021/11/Digna-Tost-Bioanalysis_Short-e1658232207238.png https://kymos.com/es/news/inmunologia-trabajando-juntos-para-prepararnos-para-la-proxima-pandemia/ 2020-05-18T08:57:45+00:00 https://kymos.com/wp-content/uploads/2021/11/Carles-Morte_Immunology_Short-e1658232189298.png https://kymos.com/ko/news/%eb%a9%b4%ec%97%ad%ed%95%99-%eb%8b%a4%ec%9d%8c-%ed%8c%ac%eb%8d%b0%eb%af%b9%ec%97%90-%eb%8c%80%eb%b9%84%ed%95%98%ea%b8%b0-%ec%9c%84%ed%95%9c-%ed%98%91%eb%a0%a5/ 2020-05-18T08:57:45+00:00 https://kymos.com/wp-content/uploads/2021/11/Carles-Morte_Immunology_Short-e1658232189298.png https://kymos.com/it/news/immunologia-lavorare-insieme-per-prepararsi-alla-prossima-pandemia/ 2020-05-18T08:57:45+00:00 https://kymos.com/wp-content/uploads/2021/11/Carles-Morte_Immunology_Short-e1658232189298.png https://kymos.com/de/news/immunologie-gemeinsam-fuer-die-naechste-pandemie-geruestet/ 2020-05-18T08:57:45+00:00 https://kymos.com/wp-content/uploads/2021/11/Carles-Morte_Immunology_Short-e1658232189298.png https://kymos.com/fr/news/immunologie-travailler-ensemble-pour-se-preparer-a-la-prochaine-pandemie/ 2020-05-18T08:57:45+00:00 https://kymos.com/wp-content/uploads/2021/11/Carles-Morte_Immunology_Short-e1658232189298.png https://kymos.com/ca/news/immunologia-treballant-junts-per-preparar-nos-per-a-la-propera-pandemia/ 2020-05-18T08:57:45+00:00 https://kymos.com/wp-content/uploads/2021/11/Carles-Morte_Immunology_Short-e1658232189298.png https://kymos.com/de/news/biopharmazeutische-globale-partner/ 2020-09-16T08:33:19+00:00 https://kymos.com/wp-content/uploads/2021/11/Biopharmaceutical-Global-Partners_srt-e1658232466300.png https://kymos.com/fr/news/partenaires-mondiaux-biopharmaceutiques/ 2020-09-16T08:33:19+00:00 https://kymos.com/wp-content/uploads/2021/11/Biopharmaceutical-Global-Partners_srt-e1658232466300.png https://kymos.com/es/news/socios-globales-biofarmaceuticos/ 2020-09-16T08:33:19+00:00 https://kymos.com/wp-content/uploads/2021/11/Biopharmaceutical-Global-Partners_srt-e1658232466300.png https://kymos.com/ca/news/socis-globals-biofarmaceutics/ 2020-09-16T08:33:19+00:00 https://kymos.com/wp-content/uploads/2021/11/Biopharmaceutical-Global-Partners_srt-e1658232466300.png https://kymos.com/ko/news/%eb%b0%94%ec%9d%b4%ec%98%a4%ec%a0%9c%ec%95%bd-%ea%b8%80%eb%a1%9c%eb%b2%8c-%ed%8c%8c%ed%8a%b8%eb%84%88/ 2020-09-16T08:33:19+00:00 https://kymos.com/wp-content/uploads/2021/11/Biopharmaceutical-Global-Partners_srt-e1658232466300.png https://kymos.com/it/news/partner-globali-biofarmaceutici/ 2020-09-16T08:33:19+00:00 https://kymos.com/wp-content/uploads/2021/11/Biopharmaceutical-Global-Partners_srt-e1658232466300.png https://kymos.com/ko/news/kymos%ec%99%80-isglobal%ec%9d%b4-%ec%95%84%ed%94%84%eb%a6%ac%ec%b9%b4%ec%9d%98-%ea%b8%b0%ec%83%9d%ec%b6%a9-%ec%a7%88%eb%b3%91%ec%9d%84-%eb%a7%89%ea%b8%b0-%ec%9c%84%ed%95%9c-%eb%85%b8%eb%a0%a5%ec%97%90/ 2021-11-30T08:24:40+00:00 https://kymos.com/wp-content/uploads/2021/11/21-11-25_STOP_Newsletter_Banner_short_small.png https://kymos.com/it/news/kymos-e-isglobal-uniscono-gli-sforzi-per-fermare-le-malattie-parassitarie-in-africa/ 2021-11-30T08:24:40+00:00 https://kymos.com/wp-content/uploads/2021/11/21-11-25_STOP_Newsletter_Banner_short_small.png https://kymos.com/de/news/kymos-und-isglobal-buendeln-ihre-kraefte-um-parasitaere-krankheiten-in-afrika-zu-stoppen/ 2021-11-30T08:24:40+00:00 https://kymos.com/wp-content/uploads/2021/11/21-11-25_STOP_Newsletter_Banner_short_small.png https://kymos.com/fr/news/kymos-et-isglobal-unissent-leurs-efforts-pour-mettre-fin-aux-maladies-parasitaires-en-afrique/ 2021-11-30T08:24:40+00:00 https://kymos.com/wp-content/uploads/2021/11/21-11-25_STOP_Newsletter_Banner_short_small.png https://kymos.com/es/news/kymos-e-isglobal-unen-esfuerzos-para-detener-las-enfermedades-parasitarias-en-africa/ 2021-11-30T08:24:40+00:00 https://kymos.com/wp-content/uploads/2021/11/21-11-25_STOP_Newsletter_Banner_short_small.png https://kymos.com/ca/news/kymos-i-isglobal-uneixen-esforcos-per-aturar-les-malalties-parasitaries-a-lafrica/ 2021-11-30T08:24:40+00:00 https://kymos.com/wp-content/uploads/2021/11/21-11-25_STOP_Newsletter_Banner_short_small.png https://kymos.com/it/news/impurita-elementari-nuove-normative-per-i-prodotti-farmaceutici-e-cosmetici-per-uso-umano-e-veterinario/ 2022-07-25T13:08:34+00:00 https://kymos.com/wp-content/uploads/2022/07/2022-07-27-Elemental-Impurities_Banner_small.png https://kymos.com/wp-content/uploads/2022/07/KYMOS-EI_ICP-MS-Agilent-7800-_20210623-BCN-1137.jpg https://kymos.com/de/news/elementare-verunreinigungen-neue-vorschriften-fuer-human-und-tierarzneimittel-sowie-kosmetikprodukte/ 2022-07-25T13:08:34+00:00 https://kymos.com/wp-content/uploads/2022/07/2022-07-27-Elemental-Impurities_Banner_small.png https://kymos.com/wp-content/uploads/2022/07/KYMOS-EI_ICP-MS-Agilent-7800-_20210623-BCN-1137.jpg https://kymos.com/fr/news/impuretes-elementaires-nouvelle-reglementation-pour-les-produits-pharmaceutiques-et-cosmetiques-a-usage-humain-et-veterinaire/ 2022-07-25T13:08:34+00:00 https://kymos.com/wp-content/uploads/2022/07/2022-07-27-Elemental-Impurities_Banner_small.png https://kymos.com/wp-content/uploads/2022/07/KYMOS-EI_ICP-MS-Agilent-7800-_20210623-BCN-1137.jpg https://kymos.com/ko/news/%ec%9b%90%ec%86%8c-%eb%b6%88%ec%88%9c%eb%ac%bc-%ec%9d%b8%ea%b0%84-%eb%b0%8f-%ec%88%98%ec%9d%98%ed%95%99-%ec%9d%98%ec%95%bd%ed%92%88%ea%b3%bc-%ed%99%94%ec%9e%a5%ed%92%88%ec%97%90-%eb%8c%80%ed%95%9c/ 2022-07-25T13:08:34+00:00 https://kymos.com/wp-content/uploads/2022/07/2022-07-27-Elemental-Impurities_Banner_small.png https://kymos.com/wp-content/uploads/2022/07/KYMOS-EI_ICP-MS-Agilent-7800-_20210623-BCN-1137.jpg https://kymos.com/es/news/impurezas-elementales-nuevas-regulaciones-para-productos-farmaceuticos-y-cosmeticos-humanos-y-veterinarios/ 2022-07-25T13:08:34+00:00 https://kymos.com/wp-content/uploads/2022/07/2022-07-27-Elemental-Impurities_Banner_small.png https://kymos.com/wp-content/uploads/2022/07/KYMOS-EI_ICP-MS-Agilent-7800-_20210623-BCN-1137.jpg https://kymos.com/ca/news/impureses-elementals-noves-regulacions-per-a-productes-farmaceutics-i-cosmetics-dus-huma-i-veterinari/ 2022-07-25T13:08:34+00:00 https://kymos.com/wp-content/uploads/2022/07/2022-07-27-Elemental-Impurities_Banner_small.png https://kymos.com/wp-content/uploads/2022/07/KYMOS-EI_ICP-MS-Agilent-7800-_20210623-BCN-1137.jpg https://kymos.com/ko/news/kymos%ec%9d%98-%ed%83%9c%ec%96%91%ea%b4%91-%ed%8c%a8%eb%84%90/ 2022-09-14T08:26:44+00:00 https://kymos.com/wp-content/uploads/2022/09/2022-09-14-Solar-Pannels_Banner-1.png https://kymos.com/it/news/pannelli-solari-a-kymos/ 2022-09-14T08:26:44+00:00 https://kymos.com/wp-content/uploads/2022/09/2022-09-14-Solar-Pannels_Banner-1.png https://kymos.com/de/news/solaranlagen-bei-kymos/ 2022-09-14T08:26:44+00:00 https://kymos.com/wp-content/uploads/2022/09/2022-09-14-Solar-Pannels_Banner-1.png https://kymos.com/fr/news/panneaux-solaires-a-kymos/ 2022-09-14T08:26:44+00:00 https://kymos.com/wp-content/uploads/2022/09/2022-09-14-Solar-Pannels_Banner-1.png https://kymos.com/ca/news/panells-solars-a-kymos/ 2022-09-14T08:26:44+00:00 https://kymos.com/wp-content/uploads/2022/09/2022-09-14-Solar-Pannels_Banner-1.png https://kymos.com/es/news/paneles-solares-en-kymos/ 2022-09-14T08:26:44+00:00 https://kymos.com/wp-content/uploads/2022/09/2022-09-14-Solar-Pannels_Banner-1.png https://kymos.com/fr/news/nouvelles-lignes-directrices-preliminaires-de-la-fda-concernant-les-therapies-oligonucleotidiques/ 2022-10-28T05:17:15+00:00 https://kymos.com/wp-content/uploads/2022/10/2022-11-02-Oligo-Guideline_Banner_small-1.png https://kymos.com/ko/news/%ec%98%ac%eb%a6%ac%ea%b3%a0%eb%89%b4%ed%81%b4%eb%a0%88%ec%98%a4%ed%8b%b0%eb%93%9c-%ec%b9%98%eb%a3%8c%ec%a0%9c%ec%97%90-%eb%8c%80%ed%95%9c-%ec%83%88%eb%a1%9c%ec%9a%b4-fda-%ec%b4%88%ec%95%88-%ec%a7%80/ 2022-10-28T05:17:15+00:00 https://kymos.com/wp-content/uploads/2022/10/2022-11-02-Oligo-Guideline_Banner_small-1.png https://kymos.com/it/news/nuova-bozza-di-linee-guida-della-fda-per-la-terapia-oligonucleotidica/ 2022-10-28T05:17:15+00:00 https://kymos.com/wp-content/uploads/2022/10/2022-11-02-Oligo-Guideline_Banner_small-1.png https://kymos.com/ca/news/nova-guia-preliminar-de-la-fda-per-a-terapeutiques-amb-oligonucleotids/ 2022-10-28T05:17:15+00:00 https://kymos.com/wp-content/uploads/2022/10/2022-11-02-Oligo-Guideline_Banner_small-1.png https://kymos.com/de/news/neuer-fda-leitlinienentwurf-fuer-oligonukleotid-therapeutika/ 2022-10-28T05:17:15+00:00 https://kymos.com/wp-content/uploads/2022/10/2022-11-02-Oligo-Guideline_Banner_small-1.png https://kymos.com/es/news/nueva-directriz-preliminar-de-la-fda-para-terapias-con-oligonucleotidos/ 2022-10-28T05:17:15+00:00 https://kymos.com/wp-content/uploads/2022/10/2022-11-02-Oligo-Guideline_Banner_small-1.png https://kymos.com/ko/news/%ec%b9%b4%ec%9d%b4%eb%aa%a8%ec%8a%a4-%ed%81%ac%eb%a6%ac%ec%8a%a4%eb%a7%88%ec%8a%a4-%ec%ba%98%eb%a6%b0%eb%8d%94/ 2022-11-30T12:59:45+00:00 https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/it/news/calendario-di-natale-di-kymos/ 2022-11-30T12:59:45+00:00 https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/ca/news/calendari-de-nadal-de-kymos/ 2022-11-30T12:59:45+00:00 https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/de/news/kymos-weihnachtskalender/ 2022-11-30T12:59:45+00:00 https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/fr/news/calendrier-de-noel-de-kymos/ 2022-11-30T12:59:45+00:00 https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/es/news/calendario-navideno-de-kymos/ 2022-11-30T12:59:45+00:00 https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/ca/news/kymos-i-prolytic-tenen-la-certificacio-cir/ 2023-01-31T08:07:53+00:00 https://kymos.com/wp-content/uploads/2023/01/2023-01-26-CIR_Banner_small.png https://kymos.com/es/news/kymos-y-prolytic-cuentan-con-certificacion-cir/ 2023-01-31T08:07:53+00:00 https://kymos.com/wp-content/uploads/2023/01/2023-01-26-CIR_Banner_small.png https://kymos.com/ko/news/kymos%ec%99%80-prolytic%ec%9d%80-cir-%ec%9d%b8%ec%a6%9d%ec%9d%84-%eb%b0%9b%ec%95%98%ec%8a%b5%eb%8b%88%eb%8b%a4/ 2023-01-31T08:07:53+00:00 https://kymos.com/wp-content/uploads/2023/01/2023-01-26-CIR_Banner_small.png https://kymos.com/it/news/kymos-e-prolytic-sono-certificati-cir/ 2023-01-31T08:07:53+00:00 https://kymos.com/wp-content/uploads/2023/01/2023-01-26-CIR_Banner_small.png https://kymos.com/de/news/kymos-und-prolytic-sind-cir-zertifiziert/ 2023-01-31T08:07:53+00:00 https://kymos.com/wp-content/uploads/2023/01/2023-01-26-CIR_Banner_small.png https://kymos.com/fr/news/kymos-et-prolytic-sont-certifies-cir/ 2023-01-31T08:07:53+00:00 https://kymos.com/wp-content/uploads/2023/01/2023-01-26-CIR_Banner_small.png https://kymos.com/ca/news/un-metode-lc-ms-ms-per-a-quatre-cannabinoides/ 2023-02-09T10:02:06+00:00 https://kymos.com/wp-content/uploads/2023/02/2023-02-15_Cannabis_Banner_3_small.png https://kymos.com/es/news/un-metodo-lc-ms-ms-para-cuatro-cannabinoides/ 2023-02-09T10:02:06+00:00 https://kymos.com/wp-content/uploads/2023/02/2023-02-15_Cannabis_Banner_3_small.png https://kymos.com/it/news/un-metodo-lc-ms-ms-per-quattro-cannabinoidi/ 2023-02-09T10:02:06+00:00 https://kymos.com/wp-content/uploads/2023/02/2023-02-15_Cannabis_Banner_3_small.png https://kymos.com/de/news/eine-lc-ms-ms-methode-fuer-vier-cannabinoide/ 2023-02-09T10:02:06+00:00 https://kymos.com/wp-content/uploads/2023/02/2023-02-15_Cannabis_Banner_3_small.png https://kymos.com/fr/news/une-methode-lc-ms-ms-pour-quatre-cannabinoides/ 2023-02-09T10:02:06+00:00 https://kymos.com/wp-content/uploads/2023/02/2023-02-15_Cannabis_Banner_3_small.png https://kymos.com/ko/news/4%ea%b0%80%ec%a7%80-%ec%b9%b8%eb%82%98%eb%b9%84%eb%85%b8%ec%9d%b4%eb%93%9c%ec%97%90-%eb%8c%80%ed%95%9c-%ed%95%98%eb%82%98%ec%9d%98-lc-ms-ms-%eb%b0%a9%eb%b2%95/ 2023-02-09T10:02:06+00:00 https://kymos.com/wp-content/uploads/2023/02/2023-02-15_Cannabis_Banner_3_small.png https://kymos.com/es/news/productos-medicinales-de-terapia-avanzada-primera-plataforma-para-virus-adenoasociados-en-terapia-genica/ 2023-06-19T12:34:46+00:00 https://kymos.com/wp-content/uploads/2023/06/Captura-2.jpg https://kymos.com/ko/news/%ea%b3%a0%ea%b8%89-%ec%b9%98%eb%a3%8c-%ec%9d%98%ec%95%bd%ed%92%88-%ec%9c%a0%ec%a0%84%ec%9e%90-%ec%b9%98%eb%a3%8c%ec%97%90%ec%84%9c-%ec%95%84%eb%8d%b0%eb%85%b8-%ec%97%b0%ea%b4%80-%eb%b0%94%ec%9d%b4/ 2023-06-19T12:34:46+00:00 https://kymos.com/wp-content/uploads/2023/06/Captura-2.jpg https://kymos.com/it/news/prodotti-medicinali-per-terapie-avanzate-prima-piattaforma-per-virus-adeno-associati-nella-terapia-genica/ 2023-06-19T12:34:46+00:00 https://kymos.com/wp-content/uploads/2023/06/Captura-2.jpg https://kymos.com/ca/news/productes-medicinals-de-terapia-avancada-primera-plataforma-per-a-virus-adenoassociats-en-terapia-genica/ 2023-06-19T12:34:46+00:00 https://kymos.com/wp-content/uploads/2023/06/Captura-2.jpg https://kymos.com/de/news/arzneimittel-fuer-neuartige-therapien-erste-plattform-fuer-adeno-assoziierte-viren-in-der-gentherapie/ 2023-06-19T12:34:46+00:00 https://kymos.com/wp-content/uploads/2023/06/Captura-2.jpg https://kymos.com/fr/news/medicaments-de-therapie-avancee-premiere-plateforme-pour-les-virus-adeno-associes-en-therapie-genique/ 2023-06-19T12:34:46+00:00 https://kymos.com/wp-content/uploads/2023/06/Captura-2.jpg https://kymos.com/ca/news/proves-de-dietilenglicol-deg-i-etilenglicol-eg-en-components-de-farmacs-dalt-risc/ 2023-07-20T13:24:04+00:00 https://kymos.com/wp-content/uploads/2023/07/DEGEG-Testing-Image.jpg https://kymos.com/es/news/pruebas-de-dietilenglicol-deg-y-etilenglicol-eg-en-componentes-de-medicamentos-de-alto-riesgo/ 2023-07-20T13:24:04+00:00 https://kymos.com/wp-content/uploads/2023/07/DEGEG-Testing-Image.jpg https://kymos.com/fr/news/tests-de-diethylene-glycol-deg-et-dethylene-glycol-eg-sur-les-composants-de-medicaments-a-haut-risque/ 2023-07-20T13:24:04+00:00 https://kymos.com/wp-content/uploads/2023/07/DEGEG-Testing-Image.jpg https://kymos.com/ko/news/%ea%b3%a0%ec%9c%84%ed%97%98-%ec%95%bd%eb%ac%bc-%ec%84%b1%eb%b6%84%ec%97%90-%eb%8c%80%ed%95%9c-%eb%94%94%ec%97%90%ed%8b%b8%eb%a0%8c%ea%b8%80%eb%a6%ac%ec%bd%9cdeg-%eb%b0%8f-%ec%97%90%ed%8b%b8%eb%a0%8c/ 2023-07-20T13:24:04+00:00 https://kymos.com/wp-content/uploads/2023/07/DEGEG-Testing-Image.jpg https://kymos.com/it/news/test-del-glicole-dietilenico-deg-e-del-glicole-etilenico-eg-sui-componenti-di-farmaci-ad-alto-rischio/ 2023-07-20T13:24:04+00:00 https://kymos.com/wp-content/uploads/2023/07/DEGEG-Testing-Image.jpg https://kymos.com/de/news/pruefung-von-diethylenglykol-deg-und-ethylenglykol-eg-an-hochriskanten-arzneimittelkomponenten/ 2023-07-20T13:24:04+00:00 https://kymos.com/wp-content/uploads/2023/07/DEGEG-Testing-Image.jpg https://kymos.com/es/news/vich-gl18-r2-cambios-en-los-disolventes-residuales-para-productos-veterinarios/ 2023-08-10T10:32:00+00:00 https://kymos.com/wp-content/uploads/2023/08/2023-07-21-Residual-Solvents-VET-Foto-Portada.jpg https://kymos.com/ko/news/vich-gl18-r2-%ec%88%98%ec%9d%98%ed%95%99-%ec%a0%9c%ed%92%88%ec%9d%98-%ec%9e%94%eb%a5%98-%ec%9a%a9%eb%a7%a4-%eb%b3%80%ea%b2%bd/ 2023-08-10T10:32:00+00:00 https://kymos.com/wp-content/uploads/2023/08/2023-07-21-Residual-Solvents-VET-Foto-Portada.jpg https://kymos.com/it/news/vich-gl18-r2-modifiche-nei-solventi-residui-per-prodotti-veterinari/ 2023-08-10T10:32:00+00:00 https://kymos.com/wp-content/uploads/2023/08/2023-07-21-Residual-Solvents-VET-Foto-Portada.jpg https://kymos.com/de/news/vich-gl18-r2-aenderungen-der-restloesungsmittel-in-tierarzneimitteln/ 2023-08-10T10:32:00+00:00 https://kymos.com/wp-content/uploads/2023/08/2023-07-21-Residual-Solvents-VET-Foto-Portada.jpg https://kymos.com/fr/news/vich-gl18-r2-modifications-apportees-aux-solvants-residuels-des-produits-veterinaires/ 2023-08-10T10:32:00+00:00 https://kymos.com/wp-content/uploads/2023/08/2023-07-21-Residual-Solvents-VET-Foto-Portada.jpg https://kymos.com/es/news/nueva-guia-de-la-fda-limites-de-ingesta-aceptable-recomendados-por-el-ndsri/ 2023-09-14T11:49:01+00:00 https://kymos.com/wp-content/uploads/2023/09/2023-09-14-FDA-Nitrosamines-Foto-blog.jpg https://kymos.com/ko/news/fda-%ec%83%88%eb%a1%9c%ec%9a%b4-%ec%a7%80%ec%b9%a8-ndsri-%ea%b6%8c%ec%9e%a5-%ed%97%88%ec%9a%a9-%ec%84%ad%ec%b7%a8-%ed%95%9c%eb%8f%84/ 2023-09-14T11:49:01+00:00 https://kymos.com/wp-content/uploads/2023/09/2023-09-14-FDA-Nitrosamines-Foto-blog.jpg https://kymos.com/it/news/nuove-linee-guida-della-fda-limiti-di-assunzione-accettabili-raccomandati-dagli-ndsri/ 2023-09-14T11:49:01+00:00 https://kymos.com/wp-content/uploads/2023/09/2023-09-14-FDA-Nitrosamines-Foto-blog.jpg https://kymos.com/de/news/neue-fda-leitlinie-empfohlene-akzeptable-aufnahmemengen-fuer-ndsris/ 2023-09-14T11:49:01+00:00 https://kymos.com/wp-content/uploads/2023/09/2023-09-14-FDA-Nitrosamines-Foto-blog.jpg https://kymos.com/fr/news/nouvelles-recommandations-de-la-fda-limites-dapport-acceptables-recommandees-pour-les-isrs/ 2023-09-14T11:49:01+00:00 https://kymos.com/wp-content/uploads/2023/09/2023-09-14-FDA-Nitrosamines-Foto-blog.jpg https://kymos.com/ca/news/forma-du-i-lean-lab-millora-de-la-productivitat-al-laboratori/ 2023-11-21T11:29:36+00:00 https://kymos.com/wp-content/uploads/2023/11/2023-11-09-U-Shape-Lean-Lab-Imagev3.jpg https://kymos.com/wp-content/uploads/2023/11/Captura.jpg https://kymos.com/es/news/u-shape-y-lean-lab-mejorando-la-productividad-en-el-laboratorio/ 2023-11-21T11:29:36+00:00 https://kymos.com/wp-content/uploads/2023/11/2023-11-09-U-Shape-Lean-Lab-Imagev3.jpg https://kymos.com/wp-content/uploads/2023/11/Captura.jpg https://kymos.com/it/news/u-shape-e-lean-lab-migliorare-la-produttivita-in-laboratorio/ 2023-11-21T11:29:36+00:00 https://kymos.com/wp-content/uploads/2023/11/2023-11-09-U-Shape-Lean-Lab-Imagev3.jpg https://kymos.com/wp-content/uploads/2023/11/Captura.jpg https://kymos.com/de/news/u-form-und-lean-lab-produktivitaetssteigerung-im-labor/ 2023-11-21T11:29:36+00:00 https://kymos.com/wp-content/uploads/2023/11/2023-11-09-U-Shape-Lean-Lab-Imagev3.jpg https://kymos.com/wp-content/uploads/2023/11/Captura.jpg https://kymos.com/fr/news/la-methode-u-shape-et-lean-lab-ameliorer-la-productivite-en-laboratoire/ 2023-11-21T11:29:36+00:00 https://kymos.com/wp-content/uploads/2023/11/2023-11-09-U-Shape-Lean-Lab-Imagev3.jpg https://kymos.com/wp-content/uploads/2023/11/Captura.jpg https://kymos.com/ko/news/u-shape-%eb%b0%8f-lean-lab-%ec%8b%a4%ed%97%98%ec%8b%a4-%ec%83%9d%ec%82%b0%ec%84%b1-%ed%96%a5%ec%83%81/ 2023-11-21T11:29:36+00:00 https://kymos.com/wp-content/uploads/2023/11/2023-11-09-U-Shape-Lean-Lab-Imagev3.jpg https://kymos.com/wp-content/uploads/2023/11/Captura.jpg https://kymos.com/ca/news/perfils-dimpureses-caracteritzacio-dimpureses-desconegudes-en-productes-farmaceutics/ 2024-01-23T07:46:04+00:00 https://kymos.com/wp-content/uploads/2024/01/2024-01-23-Impurity-Profiling-2.jpg https://kymos.com/es/news/perfil-de-impurezas-caracterizacion-de-impurezas-desconocidas-en-productos-farmaceuticos/ 2024-01-23T07:46:04+00:00 https://kymos.com/wp-content/uploads/2024/01/2024-01-23-Impurity-Profiling-2.jpg https://kymos.com/ko/news/%eb%b6%88%ec%88%9c%eb%ac%bc-%ed%94%84%eb%a1%9c%ed%8c%8c%ec%9d%bc%eb%a7%81-%ec%9d%98%ec%95%bd%ed%92%88%ec%9d%98-%ec%95%8c%eb%a0%a4%ec%a7%80%ec%a7%80-%ec%95%8a%ec%9d%80-%eb%b6%88%ec%88%9c%eb%ac%bc/ 2024-01-23T07:46:04+00:00 https://kymos.com/wp-content/uploads/2024/01/2024-01-23-Impurity-Profiling-2.jpg https://kymos.com/it/news/profilazione-delle-impurita-caratterizzazione-delle-impurita-sconosciute-nei-prodotti-farmaceutici/ 2024-01-23T07:46:04+00:00 https://kymos.com/wp-content/uploads/2024/01/2024-01-23-Impurity-Profiling-2.jpg https://kymos.com/de/news/verunreinigungsprofilierung-charakterisierung-unbekannter-verunreinigungen-in-arzneimitteln/ 2024-01-23T07:46:04+00:00 https://kymos.com/wp-content/uploads/2024/01/2024-01-23-Impurity-Profiling-2.jpg https://kymos.com/fr/news/profilage-des-impuretes-caracterisation-des-impuretes-inconnues-dans-les-produits-pharmaceutiques/ 2024-01-23T07:46:04+00:00 https://kymos.com/wp-content/uploads/2024/01/2024-01-23-Impurity-Profiling-2.jpg https://kymos.com/it/news/liraglutide-e-semaglutide-esplorazione-di-studi-biosimilari-per-gli-agonisti-del-recettore-glp-1/ 2024-02-20T13:29:44+00:00 https://kymos.com/de/news/liraglutid-semaglutid-untersuchung-von-biosimilar-studien-fuer-glp-1-rezeptoragonisten/ 2024-02-20T13:29:44+00:00 https://kymos.com/wp-content/uploads/2024/02/2024-20-02-LiraglutideSemaglutide.png https://kymos.com/fr/news/liraglutide-et-semaglutide-exploration-des-etudes-biosimilaires-pour-les-agonistes-des-recepteurs-du-glp-1/ 2024-02-20T13:29:44+00:00 https://kymos.com/wp-content/uploads/2024/02/2024-20-02-LiraglutideSemaglutide.png https://kymos.com/ko/news/%eb%a6%ac%eb%9d%bc%ea%b8%80%eb%a3%a8%ed%8b%b0%eb%93%9c-%eb%b0%8f-%ec%84%b8%eb%a7%88%ea%b8%80%eb%a3%a8%ed%8b%b0%eb%93%9c-glp-1-%ec%88%98%ec%9a%a9%ec%b2%b4-%ec%9e%91%ec%9a%a9%ec%a0%9c%ec%97%90/ 2024-02-20T13:29:44+00:00 https://kymos.com/it/news/test-di-stabilita-cosa-ci-aspetta-nel-2024/ 2024-04-05T10:28:28+00:00 https://kymos.com/de/news/stabilitaetstests-was-erwartet-uns-im-jahr-2024/ 2024-04-05T10:28:28+00:00 https://kymos.com/wp-content/uploads/2024/04/2024-28-03-Stabilities-2024-IMG-blog.png https://kymos.com/fr/news/tests-de-stabilite-que-nous-reserve-lannee-2024/ 2024-04-05T10:28:28+00:00 https://kymos.com/wp-content/uploads/2024/04/2024-28-03-Stabilities-2024-IMG-blog.png https://kymos.com/ca/news/proves-destabilitat-que-vindra-el-2024/ 2024-04-05T10:28:28+00:00 https://kymos.com/wp-content/uploads/2024/04/2024-28-03-Stabilities-2024-IMG-blog.png https://kymos.com/es/news/pruebas-de-estabilidad-que-nos-depara-el-2024/ 2024-04-05T10:28:28+00:00 https://kymos.com/wp-content/uploads/2024/04/2024-28-03-Stabilities-2024-IMG-blog.png https://kymos.com/ko/news/%ec%95%88%ec%a0%95%ec%84%b1-%ed%85%8c%ec%8a%a4%ed%8a%b8-2024%eb%85%84%ec%97%90-%eb%ac%b4%ec%97%87%ec%9d%b4-%ec%98%ac%ea%b9%8c%ec%9a%94/ 2024-04-05T10:28:28+00:00 https://kymos.com/fr/news/tests-transdermiques-analyse-et-controle-de-la-qualite-des-patchs-transdermiques/ 2024-05-31T09:19:59+00:00 https://kymos.com/wp-content/uploads/2024/05/This-week-at-Kymos-Events-19.png https://kymos.com/ko/news/%ea%b2%bd%ed%94%bc-%ec%8b%9c%ed%97%98-%ea%b2%bd%ed%94%bc-%ed%8c%a8%ec%b9%98%ec%9d%98-%eb%b6%84%ec%84%9d-%eb%b0%8f-%ed%92%88%ec%a7%88-%ea%b4%80%eb%a6%ac/ 2024-05-31T09:19:59+00:00 https://kymos.com/wp-content/uploads/2024/05/This-week-at-Kymos-Events-19.png https://kymos.com/it/news/test-transdermici-analisi-e-controllo-qualita-dei-cerotti-transdermici/ 2024-05-31T09:19:59+00:00 https://kymos.com/wp-content/uploads/2024/05/This-week-at-Kymos-Events-19.png https://kymos.com/de/news/transdermale-pruefung-analyse-und-qualitaetskontrolle-von-transdermalen-pflastern/ 2024-05-31T09:19:59+00:00 https://kymos.com/wp-content/uploads/2024/05/This-week-at-Kymos-Events-19.png https://kymos.com/ca/news/proves-transdermiques-analisi-i-control-de-qualitat-dels-pegats-transdermics/ 2024-05-31T09:19:59+00:00 https://kymos.com/wp-content/uploads/2024/05/This-week-at-Kymos-Events-19.png https://kymos.com/es/news/pruebas-transdermicas-analisis-y-control-de-calidad-de-parches-transdermicos/ 2024-05-31T09:19:59+00:00 https://kymos.com/wp-content/uploads/2024/05/This-week-at-Kymos-Events-19.png https://kymos.com/ko/news/%ec%b6%94%ec%b6%9c%eb%ac%bc-%eb%b0%8f-%ec%9a%a9%ec%b6%9c%eb%ac%bc-%eb%b6%84%ec%84%9d-%ec%97%b0%ea%b5%ac-%ec%84%a4%ea%b3%84-%eb%b0%8f-ich-q3e-%ec%a7%80%ec%b9%a8/ 2024-07-08T08:14:17+00:00 https://kymos.com/wp-content/uploads/2024/07/EL-Analysis-Study-and-ICH-Q3E.png https://kymos.com/it/news/sostanze-estraibili-e-rilasciabili-analisi-progettazione-dello-studio-e-linee-guida-ich-q3e/ 2024-07-08T08:14:17+00:00 https://kymos.com/wp-content/uploads/2024/07/EL-Analysis-Study-and-ICH-Q3E.png https://kymos.com/de/news/extrahierbare-und-auslaugbare-stoffe-analyse-studiendesign-und-ich-q3e-leitlinie/ 2024-07-08T08:14:17+00:00 https://kymos.com/wp-content/uploads/2024/07/EL-Analysis-Study-and-ICH-Q3E.png https://kymos.com/fr/news/substances-extractibles-et-relargables-analyse-conception-de-letude-et-ligne-directrice-ich-q3e/ 2024-07-08T08:14:17+00:00 https://kymos.com/wp-content/uploads/2024/07/EL-Analysis-Study-and-ICH-Q3E.png https://kymos.com/ca/news/extraibles-i-lixiviables-analisi-disseny-destudi-i-guia-ich-q3e/ 2024-07-08T08:14:17+00:00 https://kymos.com/wp-content/uploads/2024/07/EL-Analysis-Study-and-ICH-Q3E.png https://kymos.com/es/news/extraibles-y-lixiviables-analisis-diseno-del-estudio-y-guia-ich-q3e/ 2024-07-08T08:14:17+00:00 https://kymos.com/wp-content/uploads/2024/07/EL-Analysis-Study-and-ICH-Q3E.png https://kymos.com/news/advanced-therapy-medicinal-products-aav/ 2024-08-14T08:31:57+00:00 https://kymos.com/wp-content/uploads/2023/06/Captura-2.jpg https://kymos.com/news/analytical-development-validation-the-entry-gate-of-your-project/ 2024-08-14T08:36:44+00:00 https://kymos.com/wp-content/uploads/2022/02/The-Entry-Gate-to-Your-Project_srt_V2_small.png https://kymos.com/news/animal-clinical-rd-in-times-of-covid-19/ 2024-08-14T08:37:02+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos_Animal-Clinical-RD_Short-e1658232490228.png https://kymos.com/news/batch-testing-and-release-life-after-brexit/ 2024-08-14T08:37:37+00:00 https://kymos.com/wp-content/uploads/2021/11/Life-After-Brexit_srt-e1658232392922.png https://kymos.com/news/bioequivalence-studies-in-europe/ 2024-08-14T08:39:03+00:00 https://kymos.com/wp-content/uploads/2022/06/2022-06-22-Bioequivalence_Banner_small.png https://kymos.com/wp-content/uploads/2021/10/KYMOS-TEAM_DEPT_BIOAN_211007-BCN-1107-scaled.jpg https://kymos.com/news/biologics-expert-dr-carles-celma-to-speak-at-the-biosimilars-and-biologics-congress/ 2024-08-14T08:39:34+00:00 https://kymos.com/wp-content/uploads/2019/10/Biosimilars-Rome-with-Carles-Celma_short-e1658232281991.png https://kymos.com/news/biopharmaceutical-global-partners/ 2024-08-14T08:40:04+00:00 https://kymos.com/wp-content/uploads/2021/11/Biopharmaceutical-Global-Partners_srt-e1658232466300.png https://kymos.com/news/cro-market-growth/ 2024-08-14T08:41:26+00:00 https://kymos.com/wp-content/uploads/2021/11/cro_market_0.jpg https://kymos.com/news/dissolution-testing-for-all-dosage-forms/ 2024-08-14T08:42:31+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-12-Dissolution-USP-4-CE7smart_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/Dosage-forms_new.png https://kymos.com/news/dr-carles-celma-scientific-director-at-kymos-presents-successful-biologics-seminar/ 2024-08-14T08:43:54+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos-Biologics-Seminar_short-e1658232293201.png https://kymos.com/news/electrophoresis-in-quality-control-of-biologics/ 2024-08-14T08:44:40+00:00 https://kymos.com/wp-content/uploads/2021/11/ce_sciex_pa800_Electropheresis.jpg https://kymos.com/news/elemental-impurities-analysis-anticipating-our-clients-needs-before-they-need-to-ask/ 2024-08-14T08:45:05+00:00 https://kymos.com/wp-content/uploads/2021/11/Gemma-Solsona_Elemental-Impurities_Short-e1658232090249.png https://kymos.com/news/elemental-impurities-in-purified-water/ 2024-08-14T08:45:27+00:00 https://kymos.com/wp-content/uploads/2021/11/Elemental-Impurities-in-Purified-WAter.jpg https://kymos.com/news/elemental-impurities-new-regulations-for-human-veterinary-pharmaceutical-and-cosmetic-products/ 2024-08-14T08:45:53+00:00 https://kymos.com/wp-content/uploads/2022/07/2022-07-27-Elemental-Impurities_Banner_small.png https://kymos.com/wp-content/uploads/2022/07/KYMOS-EI_ICP-MS-Agilent-7800-_20210623-BCN-1137.jpg https://kymos.com/news/fit-to-purpose-bioanalytical-methods-scientific-validation/ 2024-08-14T08:46:42+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioanalytical-method-validation.jpg https://kymos.com/news/heparin-anti-factor-activity-testing/ 2024-08-14T08:47:01+00:00 https://kymos.com/wp-content/uploads/2021/11/Heparin-Anti-factor-Activity-Testing.jpg https://kymos.com/news/host-cell-proteins-analysis/ 2024-08-14T08:47:33+00:00 https://kymos.com/wp-content/uploads/2019/05/host-cell-protein-antibodies_10.32.33.jpg https://kymos.com/news/immunology-working-together-to-prepare-for-the-next-pandemic/ 2024-08-14T08:48:31+00:00 https://kymos.com/wp-content/uploads/2021/11/Carles-Morte_Immunology_Short-e1658232189298.png https://kymos.com/news/in-use-microbial-stability/ 2024-08-14T08:49:14+00:00 https://kymos.com/wp-content/uploads/2021/11/injectable_vials_Microbioal-Stability.jpg https://kymos.com/news/kymos-and-isglobal-join-efforts-to-stop-parasitic-diseases-in-africa/ 2024-08-14T08:49:41+00:00 https://kymos.com/wp-content/uploads/2021/11/21-11-25_STOP_Newsletter_Banner_short_small.png https://kymos.com/news/kymos-and-now-also-prolytic-are-cir-certified/ 2024-08-14T08:50:00+00:00 https://kymos.com/wp-content/uploads/2023/01/2023-01-26-CIR_Banner_small.png https://kymos.com/news/kymos-christmas-calendar/ 2024-08-14T08:51:24+00:00 https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/wp-content/uploads/2022/11/Christmas-Calendar2_small.png https://kymos.com/news/kymos-wins-biosuccess-award-for-consolidation-and-international-expansion-as-science-services-company/ 2024-08-14T08:51:40+00:00 https://kymos.com/wp-content/uploads/2021/11/CataloniaBio-Biosuccess-Award-2020_srt-e1658232403186.png https://kymos.com/news/macimorelin-prostaglandine/ 2024-08-14T08:53:07+00:00 https://kymos.com/wp-content/uploads/2022/03/2022-03-24Banner-ChromV3_small.png https://kymos.com/news/microbiology-adding-value-to-a-full-service/ 2024-08-14T08:53:29+00:00 https://kymos.com/wp-content/uploads/2021/11/Banner-Microbiology-short_small.png https://kymos.com/news/new-cosmetics-regulation-in-spain/ 2024-08-14T08:53:55+00:00 https://kymos.com/wp-content/uploads/2021/11/cosmetics-regulation-in-Spain.jpg https://kymos.com/news/new-fda-guidance-on-bioanalytical-method-validation/ 2024-08-14T08:54:52+00:00 https://kymos.com/wp-content/uploads/2021/11/FDA_Bioanalytical-Method-Validation.jpg https://kymos.com/news/nitrosamine-screenings-broaden-the-scope-today-reduce-costs-tomorrow/ 2024-08-14T09:11:16+00:00 https://kymos.com/wp-content/uploads/2020/04/n-nitrosamines_luca_short.png https://kymos.com/news/nucleic-acids-from-biological-underdog-to-biotech-top-dog/ 2024-08-14T09:11:37+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-05-Nucleic-Acids_Banner2_small.png https://kymos.com/news/one-lc-ms-ms-method-for-four-cannabinoids/ 2024-08-14T09:11:57+00:00 https://kymos.com/wp-content/uploads/2023/02/2023-02-15_Cannabis_Banner_3_small.png https://kymos.com/news/pharmaprogress-bright-lights-are-on-the-horizon/ 2024-08-14T09:12:37+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-28-PHP-Newsletter_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/New-Building-V2-400x243.png https://kymos.com/news/pharmaprogress-first-hand-nitrosamine-experience-pushing-the-analytical-envelope/ 2024-08-14T09:12:57+00:00 https://kymos.com/wp-content/uploads/2021/09/FirstHand-Nitrosamine-Experience_short_small.png https://kymos.com/news/pharmaprogress-real-life-cases-in-aefi-symposium-round-table-on-nitrosamines/ 2024-08-14T09:13:18+00:00 https://kymos.com/wp-content/uploads/2021/05/Banner-Luca-short.jpg https://kymos.com/news/quality-and-equivalence-of-topical-products/ 2024-08-14T09:13:41+00:00 https://kymos.com/wp-content/uploads/2019/04/hanson_franz_cells_copy_Topical-Products.jpg https://kymos.com/news/quantifying-active-enzymes-a-bioanalytical-challenge/ 2024-08-14T09:13:58+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-24-Enzyme-Activity_Banner2_small.png https://kymos.com/news/solar-panels-at-kymos/ 2024-08-14T09:14:20+00:00 https://kymos.com/wp-content/uploads/2022/09/2022-09-14-Solar-Pannels_Banner-1.png https://kymos.com/news/stability-testing-2024/ 2024-08-14T09:14:38+00:00 https://kymos.com/wp-content/uploads/2024/04/2024-28-03-Stabilities-2024-IMG-blog.png https://kymos.com/news/the-revolution-in-covid-vaccine-development/ 2024-08-14T09:14:55+00:00 https://kymos.com/wp-content/uploads/2021/07/RNA-Technology-Meike-Saul_srt-e1658232382872.png https://kymos.com/news/transdermal-testing-analysis-quality-control-transdermal-patches/ 2024-08-14T09:15:23+00:00 https://kymos.com/wp-content/uploads/2024/05/This-week-at-Kymos-Events-19.png https://kymos.com/news/u-shape-lean-lab-improving-productivity-in-laboratory/ 2024-08-14T09:15:41+00:00 https://kymos.com/wp-content/uploads/2023/11/2023-11-09-U-Shape-Lean-Lab-Imagev3.jpg https://kymos.com/wp-content/uploads/2023/11/Captura.jpg https://kymos.com/news/vaccine-potency-assay/ 2024-08-14T09:16:04+00:00 https://kymos.com/wp-content/uploads/2021/11/Vaccine-Potency-Assay.jpg https://kymos.com/news/vich-gl18-r2-changes-in-residual-solvents-for-veterinary/ 2024-08-14T09:16:23+00:00 https://kymos.com/wp-content/uploads/2023/08/2023-07-21-Residual-Solvents-VET-Foto-Portada.jpg https://kymos.com/news/what-happens-to-batch-testing-and-batch-release-after-brexit/ 2024-08-14T09:16:45+00:00 https://kymos.com/wp-content/uploads/2021/11/thumbnail_Brexit-image-Mailchimp-and-social.png https://kymos.com/news/your-stability-studies-in-safe-hands/ 2024-08-14T09:17:11+00:00 https://kymos.com/wp-content/uploads/2021/04/Stability-Newsletter_fitted-e1658237143331.png https://kymos.com/news/bioequivalence-of-topical-generic-products/ 2024-08-14T19:59:27+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioequivilance-Topical-Products.jpg https://kymos.com/news/diethylene-glycol-ethylene-glycol-contamination/ 2024-08-29T09:22:47+00:00 https://kymos.com/wp-content/uploads/2023/07/DEGEG-Testing-Image.jpg https://kymos.com/news/impurity-profiling/ 2024-08-29T09:46:18+00:00 https://kymos.com/wp-content/uploads/2024/01/2024-01-23-Impurity-Profiling-2.jpg https://kymos.com/news/extractables-leachables-analysis-study-design-ich-q3e/ 2024-08-30T09:56:51+00:00 https://kymos.com/wp-content/uploads/2024/07/EL-Analysis-Study-and-ICH-Q3E.png https://kymos.com/news/new-fda-draft-guideline-for-oligonucleotide-therapeutics/ 2024-08-30T09:59:18+00:00 https://kymos.com/wp-content/uploads/2022/10/2022-11-02-Oligo-Guideline_Banner_small-1.png https://kymos.com/news/dr-lluisa-garcia-advises-on-how-to-manage-n-nitrosamine-impurities-in-sartans/ 2024-08-30T10:02:17+00:00 https://kymos.com/wp-content/uploads/2019/12/Nitrosamines-interview-with-Lluisa_Short-e1658232221728.png https://kymos.com/news/20-years-growing-together/ 2024-08-30T10:03:51+00:00 https://kymos.com/wp-content/uploads/2021/06/20-Years-Growing-Together_srt_small.png https://kymos.com/news/kymos-approval-as-reference-lab-for-biologics-in-lebanon/ 2024-08-30T10:04:43+00:00 https://kymos.com/wp-content/uploads/2018/03/Banner_Lebanon-e1658232882595.png https://kymos.com/news/bioanalysis-harmonization-experience-and-good-practices/ 2024-08-30T10:06:44+00:00 https://kymos.com/wp-content/uploads/2021/11/Digna-Tost-Bioanalysis_Short-e1658232207238.png https://kymos.com/ko/news/ich-m10-%ec%83%9d%eb%ac%bc%eb%b6%84%ec%84%9d-%eb%b0%a9%eb%b2%95-%ea%b2%80%ec%a6%9d%ec%97%90-%eb%8c%80%ed%95%9c-ema-%eb%b0%8f-fda-%ea%b3%bc%ea%b1%b0-%ec%a7%80%ec%b9%a8-%eb%b9%84%ea%b5%90/ 2024-09-04T07:00:00+00:00 https://kymos.com/wp-content/uploads/2023/04/ICH-M10-Guideline-comparison-with-EMA-and-FDA.png https://kymos.com/it/news/confronto-tra-ich-m10-e-le-precedenti-linee-guida-ema-e-fda-sulla-convalida-dei-metodi-bioanalitici/ 2024-09-04T07:00:00+00:00 https://kymos.com/wp-content/uploads/2023/04/ICH-M10-Guideline-comparison-with-EMA-and-FDA.png https://kymos.com/de/news/vergleich-von-ich-m10-mit-frueheren-leitlinien-der-ema-und-fda-zur-validierung-bioanalytischer-methoden/ 2024-09-04T07:00:00+00:00 https://kymos.com/wp-content/uploads/2023/04/ICH-M10-Guideline-comparison-with-EMA-and-FDA.png https://kymos.com/fr/news/comparaison-de-la-norme-ich-m10-avec-les-anciennes-lignes-directrices-de-lema-et-de-la-fda-sur-la-validation-des-methodes-bioanalytiques/ 2024-09-04T07:00:00+00:00 https://kymos.com/wp-content/uploads/2023/04/ICH-M10-Guideline-comparison-with-EMA-and-FDA.png https://kymos.com/ca/news/comparacio-de-la-ich-m10-amb-les-directrius-anteriors-de-lema-i-la-fda-sobre-la-validacio-de-metodes-bioanalitics/ 2024-09-04T07:00:00+00:00 https://kymos.com/wp-content/uploads/2023/04/ICH-M10-Guideline-comparison-with-EMA-and-FDA.png https://kymos.com/es/news/comparacion-de-la-norma-ich-m10-con-las-directrices-anteriores-de-la-ema-y-la-fda-sobre-la-validacion-de-metodos-bioanaliticos/ 2024-09-04T07:00:00+00:00 https://kymos.com/wp-content/uploads/2023/04/ICH-M10-Guideline-comparison-with-EMA-and-FDA.png https://kymos.com/news/ich-m10-harmonized-guideline/ 2024-09-04T12:20:34+00:00 https://kymos.com/wp-content/uploads/2023/04/ICH-M10-Guideline-comparison-with-EMA-and-FDA.png https://kymos.com/it/news/analisi-mirna-dalla-ricerca-fondamentale-allinnovazione-di-prodotto/ 2024-10-15T10:24:57+00:00 https://kymos.com/wp-content/uploads/2024/10/microRNA-Analysis-Blog-Article-Header.png https://kymos.com/de/news/mirna-analyse-von-der-grundlagenforschung-zur-produktinnovation/ 2024-10-15T10:24:57+00:00 https://kymos.com/wp-content/uploads/2024/10/microRNA-Analysis-Blog-Article-Header.png https://kymos.com/fr/news/analyse-des-microarn-de-la-recherche-fondamentale-a-linnovation-produit/ 2024-10-15T10:24:57+00:00 https://kymos.com/wp-content/uploads/2024/10/microRNA-Analysis-Blog-Article-Header.png https://kymos.com/ko/news/mirna-%eb%b6%84%ec%84%9d-%ea%b8%b0%ec%b4%88-%ec%97%b0%ea%b5%ac%ec%97%90%ec%84%9c-%ec%a0%9c%ed%92%88-%ed%98%81%ec%8b%a0%ea%b9%8c%ec%a7%80/ 2024-10-15T10:24:57+00:00 https://kymos.com/wp-content/uploads/2024/10/microRNA-Analysis-Blog-Article-Header.png https://kymos.com/ca/news/analisi-de-mirna-de-la-recerca-fonamental-a-la-innovacio-de-productes/ 2024-10-15T10:24:57+00:00 https://kymos.com/wp-content/uploads/2024/10/microRNA-Analysis-Blog-Article-Header.png https://kymos.com/es/news/analisis-de-mirna-de-la-investigacion-fundamental-a-la-innovacion-de-productos/ 2024-10-15T10:24:57+00:00 https://kymos.com/wp-content/uploads/2024/10/microRNA-Analysis-Blog-Article-Header.png https://kymos.com/news/mirna-analysis/ 2024-10-15T10:25:49+00:00 https://kymos.com/wp-content/uploads/2024/10/microRNA-Analysis-Blog-Article-Header.png https://kymos.com/news/percutaneous-absorption-like-a-second-skin/ 2024-10-24T12:48:36+00:00 https://kymos.com/wp-content/uploads/2022/02/Percutaneous-Absorption_srt_small.png https://kymos.com/ko/news/%ea%b5%ad%ec%86%8c-%ec%a0%9c%ed%92%88%ec%97%90-%eb%8c%80%ed%95%9c-%ec%83%88%eb%a1%9c%ec%9a%b4-ema-%ec%a7%80%ec%b9%a8-ivrt-%eb%b0%8f-ivpt%ec%97%90-%eb%af%b8%ec%b9%98%eb%8a%94-%ec%98%81%ed%96%a5/ 2024-11-15T08:19:20+00:00 https://kymos.com/wp-content/uploads/2024/11/New-Guideline-Topical-Products-Header.png https://kymos.com/wp-content/uploads/2024/11/Selection-of-decision-tree-in-the-stepwise-approach-adapted-from-EMAs-guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-1-from-EMAs-Guideline-1.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-2-from-EMAs-Guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-3-from-EMAs-Guideline.png https://kymos.com/it/news/nuove-linee-guida-ema-sui-prodotti-topici-impatto-su-ivrt-e-ivpt/ 2024-11-15T08:19:20+00:00 https://kymos.com/wp-content/uploads/2024/11/New-Guideline-Topical-Products-Header.png https://kymos.com/wp-content/uploads/2024/11/Selection-of-decision-tree-in-the-stepwise-approach-adapted-from-EMAs-guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-1-from-EMAs-Guideline-1.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-2-from-EMAs-Guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-3-from-EMAs-Guideline.png https://kymos.com/de/news/neue-ema-leitlinie-zu-topischen-produkten-auswirkungen-auf-ivrt-und-ivpt/ 2024-11-15T08:19:20+00:00 https://kymos.com/wp-content/uploads/2024/11/New-Guideline-Topical-Products-Header.png https://kymos.com/wp-content/uploads/2024/11/Selection-of-decision-tree-in-the-stepwise-approach-adapted-from-EMAs-guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-1-from-EMAs-Guideline-1.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-2-from-EMAs-Guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-3-from-EMAs-Guideline.png https://kymos.com/fr/news/nouvelle-directive-de-lema-sur-les-produits-topiques-impact-sur-livrt-et-livpt/ 2024-11-15T08:19:20+00:00 https://kymos.com/wp-content/uploads/2024/11/New-Guideline-Topical-Products-Header.png https://kymos.com/wp-content/uploads/2024/11/Selection-of-decision-tree-in-the-stepwise-approach-adapted-from-EMAs-guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-1-from-EMAs-Guideline-1.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-2-from-EMAs-Guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-3-from-EMAs-Guideline.png https://kymos.com/ca/news/nova-guia-de-lema-sobre-productes-topics-impacte-en-la-radioterapia-intraventricular-rtiv-i-la-terapia-intraventricular-amb-terapia-intraventricular-ptiv/ 2024-11-15T08:19:20+00:00 https://kymos.com/wp-content/uploads/2024/11/New-Guideline-Topical-Products-Header.png https://kymos.com/wp-content/uploads/2024/11/Selection-of-decision-tree-in-the-stepwise-approach-adapted-from-EMAs-guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-1-from-EMAs-Guideline-1.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-2-from-EMAs-Guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-3-from-EMAs-Guideline.png https://kymos.com/es/news/nueva-directriz-de-la-ema-sobre-productos-topicos-impacto-en-la-ivrt-y-la-ivpt/ 2024-11-15T08:19:20+00:00 https://kymos.com/wp-content/uploads/2024/11/New-Guideline-Topical-Products-Header.png https://kymos.com/wp-content/uploads/2024/11/Selection-of-decision-tree-in-the-stepwise-approach-adapted-from-EMAs-guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-1-from-EMAs-Guideline-1.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-2-from-EMAs-Guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-3-from-EMAs-Guideline.png https://kymos.com/news/ema-guideline-topical-products/ 2024-11-15T10:57:54+00:00 https://kymos.com/wp-content/uploads/2024/11/New-Guideline-Topical-Products-Header.png https://kymos.com/wp-content/uploads/2024/11/Selection-of-decision-tree-in-the-stepwise-approach-adapted-from-EMAs-guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-1-from-EMAs-Guideline-1.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-2-from-EMAs-Guideline.png https://kymos.com/wp-content/uploads/2024/11/Decision-Tree-3-from-EMAs-Guideline.png https://kymos.com/news/new-fda-guideline-oligonucleotide-therapeutics/ 2024-11-29T12:17:54+00:00 https://kymos.com/wp-content/uploads/2024/11/header_new_fda_oligos_article.png https://kymos.com/news/endotoxin-testing/ 2025-04-28T10:46:33+00:00 https://kymos.com/wp-content/uploads/2025/04/Endotoxin-Testing-Article-Blog-Header.webp https://kymos.com/ca/news/nova-guia-de-la-fda-per-a-terapeutiques-amb-oligonucleotids/ 2025-08-06T18:31:49+00:00 https://kymos.com/wp-content/uploads/2024/11/header_new_fda_oligos_article.png https://kymos.com/ca/news/proves-dendotoxines-un-enfocament-complet-a-kymos-group/ 2025-08-06T18:31:49+00:00 https://kymos.com/wp-content/uploads/2025/04/Endotoxin-Testing-Article-Blog-Header.webp https://kymos.com/ca/news/estudis-de-bioequivalencia-a-europa/ 2025-08-07T07:36:56+00:00 https://kymos.com/wp-content/uploads/2022/06/2022-06-22-Bioequivalence_Banner_small.png https://kymos.com/wp-content/uploads/2021/10/KYMOS-TEAM_DEPT_BIOAN_211007-BCN-1107-scaled.jpg https://kymos.com/ca/news/estabilitat-microbiana-en-us/ 2025-08-07T07:36:57+00:00 https://kymos.com/wp-content/uploads/2021/11/injectable_vials_Microbioal-Stability.jpg https://kymos.com/ca/news/electroforesi-en-el-control-de-qualitat-dels-productes-biologics/ 2025-08-07T07:36:58+00:00 https://kymos.com/wp-content/uploads/2021/11/ce_sciex_pa800_Electropheresis.jpg https://kymos.com/ca/news/qualitat-i-equivalencia-dels-productes-topics/ 2025-08-07T07:37:04+00:00 https://kymos.com/wp-content/uploads/2019/04/hanson_franz_cells_copy_Topical-Products.jpg https://kymos.com/ca/news/pharmaprogress-hi-ha-llums-brillants-a-lhoritzo/ 2025-08-07T07:37:05+00:00 https://kymos.com/wp-content/uploads/2022/05/New-Building-V2-400x243.png https://kymos.com/ca/news/bioequivalencia-de-productes-generics-topics/ 2025-08-07T07:37:53+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioequivilance-Topical-Products.jpg https://kymos.com/ca/news/impureses-elementals-en-aigua-purificada/ 2025-08-07T07:37:53+00:00 https://kymos.com/wp-content/uploads/2021/11/Elemental-Impurities-in-Purified-WAter.jpg https://kymos.com/ca/news/assaig-de-potencia-de-vacunes/ 2025-08-07T07:37:53+00:00 https://kymos.com/wp-content/uploads/2021/11/Vaccine-Potency-Assay.jpg https://kymos.com/ca/news/rd-clinica-animal-en-temps-de-covid-19/ 2025-08-07T07:43:12+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos_Animal-Clinical-RD_Short-e1658232490228.png https://kymos.com/ca/news/cribratge-de-nitrosamines-amplieu-labast-avui-reduiu-els-costos-dema/ 2025-08-07T07:43:13+00:00 https://kymos.com/wp-content/uploads/2020/04/n-nitrosamines_luca_short.png https://kymos.com/ca/news/analisi-dimpureses-elementals-anticipant-les-necessitats-dels-nostres-clients-abans-que-ho-demanin/ 2025-08-07T07:43:15+00:00 https://kymos.com/wp-content/uploads/2021/11/Gemma-Solsona_Elemental-Impurities_Short-e1658232090249.png https://kymos.com/ca/news/kymos-guanya-el-premi-biosuccess-per-la-seva-consolidacio-i-expansio-internacional-com-a-empresa-de-serveis-cientifics/ 2025-08-07T07:43:15+00:00 https://kymos.com/wp-content/uploads/2021/11/CataloniaBio-Biosuccess-Award-2020_srt-e1658232403186.png https://kymos.com/ca/news/la-revolucio-en-el-desenvolupament-de-la-vacuna-contra-la-covid/ 2025-08-07T07:43:19+00:00 https://kymos.com/wp-content/uploads/2021/07/RNA-Technology-Meike-Saul_srt-e1658232382872.png https://kymos.com/ca/news/experiencia-de-primera-ma-amb-la-nitrosamina-de-pharmaprogress-superant-els-limits-de-lanalisi/ 2025-08-07T07:43:19+00:00 https://kymos.com/wp-content/uploads/2021/09/FirstHand-Nitrosamine-Experience_short_small.png https://kymos.com/ca/news/els-vostres-estudis-destabilitat-en-bones-mans/ 2025-08-07T07:43:20+00:00 https://kymos.com/wp-content/uploads/2021/04/Stability-Newsletter_fitted-e1658237143331.png https://kymos.com/ca/news/desenvolupament-analitic-i-validacio-la-porta-dentrada-del-vostre-projecte/ 2025-08-07T07:43:20+00:00 https://kymos.com/wp-content/uploads/2022/02/The-Entry-Gate-to-Your-Project_srt_V2_small.png https://kymos.com/ca/news/absorcio-percutania-com-una-segona-pell/ 2025-08-07T07:43:21+00:00 https://kymos.com/wp-content/uploads/2022/02/Percutaneous-Absorption_srt_small.png https://kymos.com/ca/news/microbiologia-afegint-valor-a-un-servei-complet/ 2025-08-07T07:43:21+00:00 https://kymos.com/wp-content/uploads/2021/11/Banner-Microbiology-short_small.png https://kymos.com/ca/news/proves-i-llancament-per-lots-la-vida-despres-del-brexit/ 2025-08-07T07:43:22+00:00 https://kymos.com/wp-content/uploads/2021/11/Life-After-Brexit_srt-e1658232392922.png https://kymos.com/ca/news/casos-reals-de-pharmaprogress-a-la-taula-rodona-del-simposi-aefi-sobre-nitrosamines/ 2025-08-07T07:43:22+00:00 https://kymos.com/wp-content/uploads/2021/05/Banner-Luca-short.jpg https://kymos.com/ca/news/20-anys-creixent-junts/ 2025-08-07T07:43:22+00:00 https://kymos.com/wp-content/uploads/2021/06/20-Years-Growing-Together_srt_small.png https://kymos.com/ca/news/quantificacio-denzims-actius-un-repte-bioanalitic/ 2025-08-07T07:43:26+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-24-Enzyme-Activity_Banner2_small.png https://kymos.com/ca/news/prolytic-i-aeterna-zentaris-20-anys-millorant-la-salut-humana-junts/ 2025-08-07T07:43:27+00:00 https://kymos.com/wp-content/uploads/2022/03/2022-03-24Banner-ChromV3_small.png https://kymos.com/ca/news/acids-nucleics-de-perdedor-biologic-a-lider-biotecnologic/ 2025-08-07T07:43:28+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-05-Nucleic-Acids_Banner2_small.png https://kymos.com/ca/news/proves-de-dissolucio-per-a-totes-les-formes-de-dosificacio/ 2025-08-07T07:43:28+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-12-Dissolution-USP-4-CE7smart_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/Dosage-forms_new.png https://kymos.com/news/fda-guidance-ndsri-recommended-ai-limits/ 2025-08-07T16:58:25+00:00 https://kymos.com/wp-content/uploads/2023/09/2023-09-14-FDA-Nitrosamines-Foto-blog.jpg https://kymos.com/es/news/ensayo-de-potencia-de-la-vacuna/ 2025-08-07T18:33:25+00:00 https://kymos.com/wp-content/uploads/2021/11/Vaccine-Potency-Assay.jpg https://kymos.com/es/news/bioequivalencia-de-productos-genericos-topicos/ 2025-08-07T18:33:26+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioequivilance-Topical-Products.jpg https://kymos.com/es/news/impurezas-elementales-en-el-agua-purificada/ 2025-08-07T18:33:26+00:00 https://kymos.com/wp-content/uploads/2021/11/Elemental-Impurities-in-Purified-WAter.jpg https://kymos.com/es/news/estabilidad-microbiana-en-uso/ 2025-08-07T18:33:26+00:00 https://kymos.com/wp-content/uploads/2021/11/injectable_vials_Microbioal-Stability.jpg https://kymos.com/es/news/electroforesis-en-el-control-de-calidad-de-productos-biologicos/ 2025-08-07T18:33:32+00:00 https://kymos.com/wp-content/uploads/2021/11/ce_sciex_pa800_Electropheresis.jpg https://kymos.com/es/news/deteccion-de-nitrosaminas-amplie-el-alcance-hoy-reduzca-los-costos-manana/ 2025-08-07T18:33:32+00:00 https://kymos.com/wp-content/uploads/2020/04/n-nitrosamines_luca_short.png https://kymos.com/es/news/el-dr-carles-celma-director-cientifico-de-kymos-presenta-con-exito-el-seminario-sobre-biologicos/ 2025-08-07T18:33:33+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos-Biologics-Seminar_short-e1658232293201.png https://kymos.com/es/news/analisis-de-impurezas-elementales-anticipandonos-a-las-necesidades-de-nuestros-clientes-antes-de-que-necesiten-preguntar/ 2025-08-07T18:33:40+00:00 https://kymos.com/wp-content/uploads/2021/11/Gemma-Solsona_Elemental-Impurities_Short-e1658232090249.png https://kymos.com/es/news/id-clinica-animal-en-tiempos-de-covid-19/ 2025-08-07T18:33:40+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos_Animal-Clinical-RD_Short-e1658232490228.png https://kymos.com/es/news/kymos-gana-el-premio-biosuccess-por-su-consolidacion-y-expansion-internacional-como-empresa-de-servicios-cientificos/ 2025-08-07T18:33:40+00:00 https://kymos.com/wp-content/uploads/2021/11/CataloniaBio-Biosuccess-Award-2020_srt-e1658232403186.png https://kymos.com/es/news/pruebas-y-lanzamiento-de-lotes-la-vida-despues-del-brexit/ 2025-08-07T18:33:41+00:00 https://kymos.com/wp-content/uploads/2021/11/Life-After-Brexit_srt-e1658232392922.png https://kymos.com/es/news/la-revolucion-en-el-desarrollo-de-la-vacuna-contra-la-covid/ 2025-08-07T18:33:41+00:00 https://kymos.com/wp-content/uploads/2021/07/RNA-Technology-Meike-Saul_srt-e1658232382872.png https://kymos.com/es/news/sus-estudios-de-estabilidad-en-buenas-manos/ 2025-08-07T18:33:41+00:00 https://kymos.com/wp-content/uploads/2021/04/Stability-Newsletter_fitted-e1658237143331.png https://kymos.com/es/news/casos-reales-de-pharmaprogress-en-la-mesa-redonda-sobre-nitrosaminas-del-simposio-aefi/ 2025-08-07T18:33:41+00:00 https://kymos.com/wp-content/uploads/2021/05/Banner-Luca-short.jpg https://kymos.com/es/news/20-anos-creciendo-juntos/ 2025-08-07T18:33:41+00:00 https://kymos.com/wp-content/uploads/2021/06/20-Years-Growing-Together_srt_small.png https://kymos.com/es/news/absorcion-percutanea-como-una-segunda-piel/ 2025-08-07T18:33:48+00:00 https://kymos.com/wp-content/uploads/2022/02/Percutaneous-Absorption_srt_small.png https://kymos.com/es/news/la-experiencia-de-primera-mano-de-pharmaprogress-con-nitrosaminas-ampliando-los-limites-analiticos/ 2025-08-07T18:33:48+00:00 https://kymos.com/wp-content/uploads/2021/09/FirstHand-Nitrosamine-Experience_short_small.png https://kymos.com/es/news/desarrollo-y-validacion-analitica-la-puerta-de-entrada-a-su-proyecto/ 2025-08-07T18:33:48+00:00 https://kymos.com/wp-content/uploads/2022/02/The-Entry-Gate-to-Your-Project_srt_V2_small.png https://kymos.com/es/news/microbiologia-anadiendo-valor-a-un-servicio-completo/ 2025-08-07T18:33:48+00:00 https://kymos.com/wp-content/uploads/2021/11/Banner-Microbiology-short_small.png https://kymos.com/es/news/acidos-nucleicos-de-perdedores-biologicos-a-lideres-biotecnologicos/ 2025-08-07T18:33:49+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-05-Nucleic-Acids_Banner2_small.png https://kymos.com/es/news/cuantificacion-de-enzimas-activas-un-desafio-bioanalitico/ 2025-08-07T18:33:49+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-24-Enzyme-Activity_Banner2_small.png https://kymos.com/es/news/prolytic-y-aeterna-zentaris-20-anos-mejorando-juntos-la-salud-humana/ 2025-08-07T18:33:49+00:00 https://kymos.com/wp-content/uploads/2022/03/2022-03-24Banner-ChromV3_small.png https://kymos.com/es/news/pruebas-de-disolucion-para-todas-las-formas-de-dosificacion/ 2025-08-07T18:33:49+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-12-Dissolution-USP-4-CE7smart_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/Dosage-forms_new.png https://kymos.com/es/news/pharmaprogress-se-vislumbran-luces-brillantes-en-el-horizonte/ 2025-08-07T18:33:49+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-28-PHP-Newsletter_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/New-Building-V2-400x243.png https://kymos.com/es/news/estudios-de-bioequivalencia-en-europa/ 2025-08-07T18:33:53+00:00 https://kymos.com/wp-content/uploads/2022/06/2022-06-22-Bioequivalence_Banner_small.png https://kymos.com/wp-content/uploads/2021/10/KYMOS-TEAM_DEPT_BIOAN_211007-BCN-1107-scaled.jpg https://kymos.com/es/news/nueva-directriz-de-la-fda-para-terapias-con-oligonucleotidos/ 2025-08-07T18:34:10+00:00 https://kymos.com/wp-content/uploads/2024/11/header_new_fda_oligos_article.png https://kymos.com/es/news/pruebas-de-endotoxinas-un-enfoque-integral-en-kymos-group/ 2025-08-07T18:34:10+00:00 https://kymos.com/wp-content/uploads/2025/04/Endotoxin-Testing-Article-Blog-Header.webp https://kymos.com/news/neutralizing-antibodies-testing/ 2025-10-02T11:41:09+00:00 https://kymos.com/wp-content/uploads/2025/09/Neutralizing-Antibodies-Main-Image.png https://kymos.com/es/news/analisis-anticuerpos-neutralizantes/ 2025-10-02T12:00:16+00:00 https://kymos.com/wp-content/uploads/2025/09/Neutralizing-Antibodies-Main-Image.png https://kymos.com/es/news/prueba-de-disolucion/ 2025-10-02T12:05:33+00:00 https://kymos.com/wp-content/uploads/2025/06/Dissolution-Testing-Article-Blog-Header.png https://kymos.com/ca/news/assaig-de-dissolucio/ 2025-10-02T12:07:07+00:00 https://kymos.com/wp-content/uploads/2025/06/Dissolution-Testing-Article-Blog-Header.png https://kymos.com/ca/news/oligoxplorer/ 2025-10-30T08:15:58+00:00 https://kymos.com/wp-content/uploads/2025/10/Header-Blog-OligoXplorer-Article.png https://kymos.com/es/news/oligoxplorer/ 2025-10-30T08:23:03+00:00 https://kymos.com/wp-content/uploads/2025/10/Header-Blog-OligoXplorer-Article.png https://kymos.com/ca/news/el-dr-carles-celma-expert-en-biologia-parlara-al-congres-de-biosimilars-i-biologia/ 2025-10-30T12:50:55+00:00 https://kymos.com/wp-content/uploads/2019/10/Biosimilars-Rome-with-Carles-Celma_short-e1658232281991.png https://kymos.com/ca/news/el-dr-carles-celma-director-cientific-de-kymos-presenta-amb-exit-un-seminari-de-biologia/ 2025-10-30T12:51:33+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos-Biologics-Seminar_short-e1658232293201.png https://kymos.com/news/denosumab-biosimilars/ 2025-10-30T13:02:17+00:00 https://kymos.com/wp-content/uploads/2025/01/Denosumab-Biosimilars-Article-Header-1.png https://kymos.com/news/liraglutide-semaglutide-biosimilars/ 2025-10-30T13:02:29+00:00 https://kymos.com/wp-content/uploads/2024/02/2024-20-02-LiraglutideSemaglutide.png https://kymos.com/es/news/biosimilar-development-change/ 2025-11-07T10:07:59+00:00 https://kymos.com/wp-content/uploads/2025/11/Biosimilar-Development-Article-Header.png https://kymos.com/ca/news/biosimilar-development-change/ 2025-11-07T10:08:18+00:00 https://kymos.com/wp-content/uploads/2025/11/Biosimilar-Development-Article-Header.png https://kymos.com/ko/news/%eb%b0%b1%ec%8b%a0-%ed%9a%a8%eb%8a%a5-%ea%b2%80%ec%a0%95/ 2025-12-03T17:58:03+00:00 https://kymos.com/wp-content/uploads/2021/11/Vaccine-Potency-Assay.jpg https://kymos.com/it/news/saggio-di-potenza-del-vaccino/ 2025-12-03T17:58:03+00:00 https://kymos.com/wp-content/uploads/2021/11/Vaccine-Potency-Assay.jpg https://kymos.com/de/news/impfstoff-potenztest/ 2025-12-03T17:58:03+00:00 https://kymos.com/wp-content/uploads/2021/11/Vaccine-Potency-Assay.jpg https://kymos.com/fr/news/essai-de-puissance-vaccinale/ 2025-12-03T17:58:03+00:00 https://kymos.com/wp-content/uploads/2021/11/Vaccine-Potency-Assay.jpg https://kymos.com/ko/news/%ea%b5%ad%ec%86%8c-%ec%a0%9c%eb%84%a4%eb%a6%ad-%ec%a0%9c%ed%92%88%ec%9d%98-%ec%83%9d%eb%ac%bc%ed%95%99%ec%a0%81-%eb%8f%99%eb%93%b1%ec%84%b1/ 2025-12-03T17:58:16+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioequivilance-Topical-Products.jpg https://kymos.com/it/news/bioequivalenza-dei-prodotti-generici-topici/ 2025-12-03T17:58:16+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioequivilance-Topical-Products.jpg https://kymos.com/fr/news/impuretes-elementaires-dans-leau-purifiee/ 2025-12-03T17:58:33+00:00 https://kymos.com/wp-content/uploads/2021/11/Elemental-Impurities-in-Purified-WAter.jpg https://kymos.com/ko/news/%ec%82%ac%ec%9a%a9-%ec%a4%91-%eb%af%b8%ec%83%9d%eb%ac%bc-%ec%95%88%ec%a0%95%ec%84%b1/ 2025-12-03T17:58:33+00:00 https://kymos.com/wp-content/uploads/2021/11/injectable_vials_Microbioal-Stability.jpg https://kymos.com/it/news/stabilita-microbica-in-uso/ 2025-12-03T17:58:33+00:00 https://kymos.com/wp-content/uploads/2021/11/injectable_vials_Microbioal-Stability.jpg https://kymos.com/de/news/mikrobielle-stabilitaet-im-gebrauch/ 2025-12-03T17:58:33+00:00 https://kymos.com/wp-content/uploads/2021/11/injectable_vials_Microbioal-Stability.jpg https://kymos.com/fr/news/stabilite-microbiologique-en-cours-dutilisation/ 2025-12-03T17:58:33+00:00 https://kymos.com/wp-content/uploads/2021/11/injectable_vials_Microbioal-Stability.jpg https://kymos.com/de/news/bioaequivalenz-topischer-generika/ 2025-12-03T17:58:35+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioequivilance-Topical-Products.jpg https://kymos.com/fr/news/bioequivalence-des-produits-generiques-topiques/ 2025-12-03T17:58:36+00:00 https://kymos.com/wp-content/uploads/2021/11/Bioequivilance-Topical-Products.jpg https://kymos.com/ko/news/%ec%a0%95%ec%a0%9c%ec%88%98%ec%9d%98-%ec%9b%90%ec%86%8c-%eb%b6%88%ec%88%9c%eb%ac%bc/ 2025-12-03T17:58:36+00:00 https://kymos.com/wp-content/uploads/2021/11/Elemental-Impurities-in-Purified-WAter.jpg https://kymos.com/it/news/impurita-elementari-nellacqua-purificata/ 2025-12-03T17:58:36+00:00 https://kymos.com/wp-content/uploads/2021/11/Elemental-Impurities-in-Purified-WAter.jpg https://kymos.com/de/news/elementare-verunreinigungen-in-gereinigtem-wasser/ 2025-12-03T17:58:36+00:00 https://kymos.com/wp-content/uploads/2021/11/Elemental-Impurities-in-Purified-WAter.jpg https://kymos.com/ko/news/%ec%83%9d%eb%ac%bc%ed%95%99-%ec%a0%9c%ec%a0%9c%ec%9d%98-%ed%92%88%ec%a7%88-%ea%b4%80%eb%a6%ac%ec%97%90%ec%84%9c%ec%9d%98-%ec%a0%84%ea%b8%b0%ec%98%81%eb%8f%99/ 2025-12-03T17:58:50+00:00 https://kymos.com/wp-content/uploads/2021/11/ce_sciex_pa800_Electropheresis.jpg https://kymos.com/it/news/elettroforesi-nel-controllo-di-qualita-dei-prodotti-biologici/ 2025-12-03T17:58:50+00:00 https://kymos.com/wp-content/uploads/2021/11/ce_sciex_pa800_Electropheresis.jpg https://kymos.com/de/news/elektrophorese-in-der-qualitaetskontrolle-von-biologika/ 2025-12-03T17:58:50+00:00 https://kymos.com/wp-content/uploads/2021/11/ce_sciex_pa800_Electropheresis.jpg https://kymos.com/fr/news/electrophorese-dans-le-controle-de-la-qualite-des-produits-biologiques/ 2025-12-03T17:58:50+00:00 https://kymos.com/wp-content/uploads/2021/11/ce_sciex_pa800_Electropheresis.jpg https://kymos.com/ko/news/kymos%ec%9d%98-%ea%b3%bc%ed%95%99-%ec%b1%85%ec%9e%84%ec%9e%90%ec%9d%b8-carles-celma-%eb%b0%95%ec%82%ac%ea%b0%80-%ec%84%b1%ea%b3%b5%ec%a0%81%ec%9d%b8-%ec%83%9d%eb%ac%bc%ed%95%99-%ec%84%b8%eb%af%b8/ 2025-12-03T17:59:06+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos-Biologics-Seminar_short-e1658232293201.png https://kymos.com/it/news/il-dott-carles-celma-direttore-scientifico-di-kymos-presenta-un-seminario-di-successo-sui-prodotti-biologici/ 2025-12-03T17:59:06+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos-Biologics-Seminar_short-e1658232293201.png https://kymos.com/de/news/dr-carles-celma-wissenschaftlicher-direktor-bei-kymos-praesentiert-ein-erfolgreiches-biologika-seminar/ 2025-12-03T17:59:06+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos-Biologics-Seminar_short-e1658232293201.png https://kymos.com/fr/news/le-dr-carles-celma-directeur-scientifique-de-kymos-presente-un-seminaire-reussi-sur-les-produits-biologiques/ 2025-12-03T17:59:06+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos-Biologics-Seminar_short-e1658232293201.png https://kymos.com/fr/news/depistage-des-nitrosamines-elargissez-le-champ-dinvestigation-aujourdhui-reduisez-les-couts-demain/ 2025-12-03T17:59:26+00:00 https://kymos.com/wp-content/uploads/2020/04/n-nitrosamines_luca_short.png https://kymos.com/ko/news/%eb%8b%88%ed%8a%b8%eb%a1%9c%ec%82%ac%eb%af%bc-%ea%b2%80%ec%82%ac-%ec%98%a4%eb%8a%98%ec%9d%80-%eb%b2%94%ec%9c%84%eb%a5%bc-%eb%84%93%ed%9e%88%ea%b3%a0-%eb%82%b4%ec%9d%bc%ec%9d%80-%eb%b9%84%ec%9a%a9/ 2025-12-03T17:59:32+00:00 https://kymos.com/wp-content/uploads/2020/04/n-nitrosamines_luca_short.png https://kymos.com/it/news/screening-delle-nitrosammine-ampliare-la-portata-oggi-ridurre-i-costi-domani/ 2025-12-03T17:59:32+00:00 https://kymos.com/wp-content/uploads/2020/04/n-nitrosamines_luca_short.png https://kymos.com/de/news/nitrosamin-screenings-heute-den-umfang-erweitern-morgen-die-kosten-senken/ 2025-12-03T17:59:32+00:00 https://kymos.com/wp-content/uploads/2020/04/n-nitrosamines_luca_short.png https://kymos.com/it/news/ricerca-e-sviluppo-clinico-animale-ai-tempi-del-covid-19/ 2025-12-03T17:59:47+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos_Animal-Clinical-RD_Short-e1658232490228.png https://kymos.com/de/news/klinische-tierforschung-und-entwicklung-in-zeiten-von-covid-19/ 2025-12-03T17:59:47+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos_Animal-Clinical-RD_Short-e1658232490228.png https://kymos.com/fr/news/recherche-et-developpement-clinique-animale-en-periode-de-covid-19/ 2025-12-03T17:59:47+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos_Animal-Clinical-RD_Short-e1658232490228.png https://kymos.com/ko/news/%ec%9b%90%ec%86%8c-%eb%b6%88%ec%88%9c%eb%ac%bc-%eb%b6%84%ec%84%9d-%ea%b3%a0%ea%b0%9d%ec%9d%b4-%ec%9a%94%ec%b2%ad%ed%95%98%ea%b8%b0-%ec%a0%84%ec%97%90-%ea%b3%a0%ea%b0%9d%ec%9d%98-%ec%9a%94%ea%b5%ac/ 2025-12-03T17:59:52+00:00 https://kymos.com/wp-content/uploads/2021/11/Gemma-Solsona_Elemental-Impurities_Short-e1658232090249.png https://kymos.com/it/news/analisi-delle-impurita-elementari-anticipare-le-esigenze-dei-nostri-clienti-prima-che-ce-le-chiedano/ 2025-12-03T17:59:52+00:00 https://kymos.com/wp-content/uploads/2021/11/Gemma-Solsona_Elemental-Impurities_Short-e1658232090249.png https://kymos.com/de/news/elementare-verunreinigungsanalyse-wir-antizipieren-die-beduerfnisse-unserer-kunden-bevor-sie-danach-fragen-muessen/ 2025-12-03T17:59:52+00:00 https://kymos.com/wp-content/uploads/2021/11/Gemma-Solsona_Elemental-Impurities_Short-e1658232090249.png https://kymos.com/fr/news/analyse-des-impuretes-elementaires-anticiper-les-besoins-de-nos-clients-avant-meme-quils-ne-les-expriment/ 2025-12-03T17:59:52+00:00 https://kymos.com/wp-content/uploads/2021/11/Gemma-Solsona_Elemental-Impurities_Short-e1658232090249.png https://kymos.com/ko/news/covid-19-%ec%8b%9c%eb%8c%80%ec%9d%98-%eb%8f%99%eb%ac%bc-%ec%9e%84%ec%83%81-rd/ 2025-12-03T17:59:53+00:00 https://kymos.com/wp-content/uploads/2021/11/Kymos_Animal-Clinical-RD_Short-e1658232490228.png https://kymos.com/ko/news/kymos-%ea%b3%bc%ed%95%99-%ec%84%9c%eb%b9%84%ec%8a%a4-%ea%b8%b0%ec%97%85%ec%9c%bc%eb%a1%9c%ec%84%9c%ec%9d%98-%ed%86%b5%ed%95%a9-%eb%b0%8f-%ea%b5%ad%ec%a0%9c%ec%a0%81-%ed%99%95%ec%9e%a5%ec%9c%bc/ 2025-12-03T18:00:12+00:00 https://kymos.com/wp-content/uploads/2021/11/CataloniaBio-Biosuccess-Award-2020_srt-e1658232403186.png https://kymos.com/it/news/kymos-vince-il-biosuccess-award-per-il-consolidamento-e-lespansione-internazionale-come-azienda-di-servizi-scientifici/ 2025-12-03T18:00:12+00:00 https://kymos.com/wp-content/uploads/2021/11/CataloniaBio-Biosuccess-Award-2020_srt-e1658232403186.png https://kymos.com/de/news/kymos-gewinnt-den-biosuccess-award-fuer-konsolidierung-und-internationale-expansion-als-wissenschaftsdienstleistungsunternehmen/ 2025-12-03T18:00:12+00:00 https://kymos.com/wp-content/uploads/2021/11/CataloniaBio-Biosuccess-Award-2020_srt-e1658232403186.png https://kymos.com/fr/news/kymos-remporte-le-prix-biosuccess-pour-sa-consolidation-et-son-expansion-internationale-en-tant-quentreprise-de-services-scientifiques/ 2025-12-03T18:00:13+00:00 https://kymos.com/wp-content/uploads/2021/11/CataloniaBio-Biosuccess-Award-2020_srt-e1658232403186.png https://kymos.com/ko/news/%ec%9d%bc%ea%b4%84-%ed%85%8c%ec%8a%a4%ed%8a%b8-%eb%b0%8f-%ec%b6%9c%ec%8b%9c-%eb%b8%8c%eb%a0%89%ec%8b%9c%ed%8a%b8-%ec%9d%b4%ed%9b%84%ec%9d%98-%ec%82%b6/ 2025-12-03T18:00:38+00:00 https://kymos.com/wp-content/uploads/2021/11/Life-After-Brexit_srt-e1658232392922.png https://kymos.com/it/news/test-e-rilascio-in-batch-la-vita-dopo-la-brexit/ 2025-12-03T18:00:38+00:00 https://kymos.com/wp-content/uploads/2021/11/Life-After-Brexit_srt-e1658232392922.png https://kymos.com/it/news/la-rivoluzione-nello-sviluppo-del-vaccino-covid/ 2025-12-03T18:00:39+00:00 https://kymos.com/wp-content/uploads/2021/07/RNA-Technology-Meike-Saul_srt-e1658232382872.png https://kymos.com/de/news/die-revolution-in-der-covid-impfstoffentwicklung/ 2025-12-03T18:00:39+00:00 https://kymos.com/wp-content/uploads/2021/07/RNA-Technology-Meike-Saul_srt-e1658232382872.png https://kymos.com/fr/news/la-revolution-dans-le-developpement-des-vaccins-contre-la-covid-19/ 2025-12-03T18:00:39+00:00 https://kymos.com/wp-content/uploads/2021/07/RNA-Technology-Meike-Saul_srt-e1658232382872.png https://kymos.com/de/news/batch-testing-und-freigabe-leben-nach-dem-brexit/ 2025-12-03T18:00:39+00:00 https://kymos.com/wp-content/uploads/2021/11/Life-After-Brexit_srt-e1658232392922.png https://kymos.com/fr/news/tests-par-lots-et-mise-en-circulation-la-vie-apres-le-brexit/ 2025-12-03T18:00:39+00:00 https://kymos.com/wp-content/uploads/2021/11/Life-After-Brexit_srt-e1658232392922.png https://kymos.com/ko/news/%ec%bd%94%eb%a1%9c%eb%82%98-%eb%b0%b1%ec%8b%a0-%ea%b0%9c%eb%b0%9c%ec%9d%98-%ed%98%81%eb%aa%85/ 2025-12-03T18:00:39+00:00 https://kymos.com/wp-content/uploads/2021/07/RNA-Technology-Meike-Saul_srt-e1658232382872.png https://kymos.com/ko/news/%ec%95%88%ec%a0%84%ed%95%9c-%ec%86%90%ec%97%90-%eb%a7%a1%ea%b2%a8%ec%a7%84-%ec%95%88%ec%a0%95%ec%84%b1-%ec%97%b0%ea%b5%ac/ 2025-12-03T18:00:40+00:00 https://kymos.com/wp-content/uploads/2021/04/Stability-Newsletter_fitted-e1658237143331.png https://kymos.com/de/news/ihre-stabilitaetsstudien-in-sicheren-haenden/ 2025-12-03T18:00:58+00:00 https://kymos.com/wp-content/uploads/2021/04/Stability-Newsletter_fitted-e1658237143331.png https://kymos.com/fr/news/etudes-de-cas-reelles-de-pharmaprogress-lors-du-symposium-aefi-table-ronde-sur-les-nitrosamines/ 2025-12-03T18:00:59+00:00 https://kymos.com/wp-content/uploads/2021/05/Banner-Luca-short.jpg https://kymos.com/fr/news/vos-etudes-de-stabilite-entre-de-bonnes-mains/ 2025-12-03T18:00:59+00:00 https://kymos.com/wp-content/uploads/2021/04/Stability-Newsletter_fitted-e1658237143331.png https://kymos.com/ko/news/pharmaprogress%ec%9d%98-aefi-%ec%8b%ac%ed%8f%ac%ec%a7%80%ec%97%84%ec%97%90%ec%84%9c-%eb%8b%88%ed%8a%b8%eb%a1%9c%ec%82%ac%eb%af%bc%ec%97%90-%eb%8c%80%ed%95%9c-%ec%8b%a4%ec%a0%9c-%ec%82%ac%eb%a1%80/ 2025-12-03T18:00:59+00:00 https://kymos.com/wp-content/uploads/2021/05/Banner-Luca-short.jpg https://kymos.com/it/news/casi-reali-di-pharmaprogress-nella-tavola-rotonda-del-simposio-aefi-sulle-nitrosammine/ 2025-12-03T18:00:59+00:00 https://kymos.com/wp-content/uploads/2021/05/Banner-Luca-short.jpg https://kymos.com/ko/news/20%eb%85%84-%eb%8f%99%ec%95%88-%ed%95%a8%ea%bb%98-%ec%84%b1%ec%9e%a5%ed%95%98%eb%a9%b0/ 2025-12-03T18:01:00+00:00 https://kymos.com/wp-content/uploads/2021/06/20-Years-Growing-Together_srt_small.png https://kymos.com/it/news/20-anni-di-crescita-insieme/ 2025-12-03T18:01:00+00:00 https://kymos.com/wp-content/uploads/2021/06/20-Years-Growing-Together_srt_small.png https://kymos.com/de/news/pharmaprogress-praesentierte-fallbeispiele-aus-der-praxis-im-rahmen-des-aefi-symposiums-runder-tisch-zum-thema-nitrosamine/ 2025-12-03T18:01:00+00:00 https://kymos.com/wp-content/uploads/2021/05/Banner-Luca-short.jpg https://kymos.com/de/news/20-jahre-gemeinsames-wachstum/ 2025-12-03T18:01:01+00:00 https://kymos.com/wp-content/uploads/2021/06/20-Years-Growing-Together_srt_small.png https://kymos.com/fr/news/20-ans-a-grandir-ensemble/ 2025-12-03T18:01:01+00:00 https://kymos.com/wp-content/uploads/2021/06/20-Years-Growing-Together_srt_small.png https://kymos.com/ko/news/%ea%b2%bd%ed%94%bc-%ed%9d%a1%ec%88%98-%eb%91%90-%eb%b2%88%ec%a7%b8-%ed%94%bc%eb%b6%80%ec%99%80-%ea%b0%99%ec%9d%80/ 2025-12-03T18:01:19+00:00 https://kymos.com/wp-content/uploads/2022/02/Percutaneous-Absorption_srt_small.png https://kymos.com/it/news/assorbimento-percutaneo-come-una-seconda-pelle/ 2025-12-03T18:01:20+00:00 https://kymos.com/wp-content/uploads/2022/02/Percutaneous-Absorption_srt_small.png https://kymos.com/de/news/perkutane-absorption-wie-eine-zweite-haut/ 2025-12-03T18:01:20+00:00 https://kymos.com/wp-content/uploads/2022/02/Percutaneous-Absorption_srt_small.png https://kymos.com/fr/news/absorption-percutanee-comme-une-seconde-peau/ 2025-12-03T18:01:20+00:00 https://kymos.com/wp-content/uploads/2022/02/Percutaneous-Absorption_srt_small.png https://kymos.com/ko/news/pharmaprogress%ec%9d%98-%eb%8b%88%ed%8a%b8%eb%a1%9c%ec%82%ac%eb%af%bc-%ec%a7%81%ec%a0%91-%ea%b2%bd%ed%97%98-%eb%b6%84%ec%84%9d%ec%9d%98-%ed%95%9c%ea%b3%84%eb%a5%bc-%eb%9b%b0%ec%96%b4%eb%84%98/ 2025-12-03T18:01:21+00:00 https://kymos.com/wp-content/uploads/2021/09/FirstHand-Nitrosamine-Experience_short_small.png https://kymos.com/ko/news/%eb%b6%84%ec%84%9d-%ea%b0%9c%eb%b0%9c-%eb%b0%8f-%ea%b2%80%ec%a6%9d-%ed%94%84%eb%a1%9c%ec%a0%9d%ed%8a%b8%ec%9d%98-%ec%8b%9c%ec%9e%91%ec%a0%90/ 2025-12-03T18:01:23+00:00 https://kymos.com/wp-content/uploads/2022/02/The-Entry-Gate-to-Your-Project_srt_V2_small.png https://kymos.com/it/news/lesperienza-diretta-di-pharmaprogress-con-la-nitrosamina-spingersi-oltre-i-limiti-analitici/ 2025-12-03T18:01:23+00:00 https://kymos.com/wp-content/uploads/2021/09/FirstHand-Nitrosamine-Experience_short_small.png https://kymos.com/de/news/pharmaprogress-nitrosamin-erfahrung-aus-erster-hand-die-grenzen-der-analytik-erweitern/ 2025-12-03T18:01:23+00:00 https://kymos.com/wp-content/uploads/2021/09/FirstHand-Nitrosamine-Experience_short_small.png https://kymos.com/fr/news/experience-directe-de-pharmaprogress-avec-les-nitrosamines-repousser-les-limites-de-lanalyse/ 2025-12-03T18:01:23+00:00 https://kymos.com/wp-content/uploads/2021/09/FirstHand-Nitrosamine-Experience_short_small.png https://kymos.com/it/news/sviluppo-analitico-e-convalida-la-porta-d39ingresso-del-tuo-progetto/ 2025-12-03T18:01:24+00:00 https://kymos.com/wp-content/uploads/2022/02/The-Entry-Gate-to-Your-Project_srt_V2_small.png https://kymos.com/fr/news/microbiologie-une-valeur-ajoutee-a-un-service-complet/ 2025-12-03T18:01:32+00:00 https://kymos.com/wp-content/uploads/2021/11/Banner-Microbiology-short_small.png https://kymos.com/de/news/analytische-entwicklung-validierung-das-eingangstor-zu-ihrem-projekt/ 2025-12-03T18:01:41+00:00 https://kymos.com/wp-content/uploads/2022/02/The-Entry-Gate-to-Your-Project_srt_V2_small.png https://kymos.com/fr/news/developpement-et-validation-analytiques-la-porte-dentree-de-votre-projet/ 2025-12-03T18:01:41+00:00 https://kymos.com/wp-content/uploads/2022/02/The-Entry-Gate-to-Your-Project_srt_V2_small.png https://kymos.com/ko/news/%eb%af%b8%ec%83%9d%eb%ac%bc%ed%95%99-%ec%a0%84%ec%b2%b4-%ec%84%9c%eb%b9%84%ec%8a%a4%ec%97%90-%ea%b0%80%ec%b9%98%eb%a5%bc-%eb%8d%94%ed%95%98%eb%8b%a4/ 2025-12-03T18:01:41+00:00 https://kymos.com/wp-content/uploads/2021/11/Banner-Microbiology-short_small.png https://kymos.com/it/news/microbiologia-aggiungere-valore-a-un-servizio-completo/ 2025-12-03T18:01:42+00:00 https://kymos.com/wp-content/uploads/2021/11/Banner-Microbiology-short_small.png https://kymos.com/de/news/mikrobiologie-mehrwert-fuer-einen-komplettservice/ 2025-12-03T18:01:42+00:00 https://kymos.com/wp-content/uploads/2021/11/Banner-Microbiology-short_small.png https://kymos.com/it/news/quantificazione-degli-enzimi-attivi-una-sfida-bioanalitica/ 2025-12-03T18:02:00+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-24-Enzyme-Activity_Banner2_small.png https://kymos.com/de/news/quantifizierung-aktiver-enzyme-eine-bioanalytische-herausforderung/ 2025-12-03T18:02:00+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-24-Enzyme-Activity_Banner2_small.png https://kymos.com/fr/news/quantification-des-enzymes-actives-un-defi-bioanalytique/ 2025-12-03T18:02:00+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-24-Enzyme-Activity_Banner2_small.png https://kymos.com/ko/news/prolytic%ea%b3%bc-aeterna-zentaris-20%eb%85%84-%eb%8f%99%ec%95%88-%ec%9d%b8%eb%a5%98-%ea%b1%b4%ea%b0%95%ec%9d%84-%ed%95%a8%ea%bb%98-%ea%b0%9c%ec%84%a0%ed%95%b4-%ec%99%94%ec%8a%b5%eb%8b%88%eb%8b%a4/ 2025-12-03T18:02:01+00:00 https://kymos.com/wp-content/uploads/2022/03/2022-03-24Banner-ChromV3_small.png https://kymos.com/it/news/prolytic-e-aeterna-zentaris-20-anni-insieme-per-migliorare-la-salute-umana/ 2025-12-03T18:02:01+00:00 https://kymos.com/wp-content/uploads/2022/03/2022-03-24Banner-ChromV3_small.png https://kymos.com/ko/news/%ed%95%b5%ec%82%b0-%ec%83%9d%eb%ac%bc%ed%95%99%ec%a0%81-%ec%95%bd%ec%9e%90%ec%97%90%ec%84%9c-%eb%b0%94%ec%9d%b4%ec%98%a4%ea%b8%b0%ec%88%a0%ec%9d%98-%ea%b0%95%ec%9e%90%eb%a1%9c/ 2025-12-03T18:02:03+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-05-Nucleic-Acids_Banner2_small.png https://kymos.com/it/news/acidi-nucleici-da-sfavoriti-della-biologia-a-campioni-della-biotecnologia/ 2025-12-03T18:02:03+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-05-Nucleic-Acids_Banner2_small.png https://kymos.com/de/news/nukleinsaeuren-vom-biologischen-aussenseiter-zum-spitzenreiter-der-biotechnologie/ 2025-12-03T18:02:03+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-05-Nucleic-Acids_Banner2_small.png https://kymos.com/ko/news/%ed%99%9c%ec%84%b1-%ed%9a%a8%ec%86%8c-%ec%a0%95%eb%9f%89%ed%99%94-%ec%83%9d%eb%ac%bc-%eb%b6%84%ec%84%9d-%ea%b3%bc%ec%a0%9c/ 2025-12-03T18:02:04+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-24-Enzyme-Activity_Banner2_small.png https://kymos.com/fr/news/acides-nucleiques-de-petit-poucet-biologique-a-star-des-biotechnologies/ 2025-12-03T18:02:04+00:00 https://kymos.com/wp-content/uploads/2022/02/2022-02-05-Nucleic-Acids_Banner2_small.png https://kymos.com/fr/news/tests-de-dissolution-pour-toutes-les-formes-posologiques/ 2025-12-03T18:02:20+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-12-Dissolution-USP-4-CE7smart_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/Dosage-forms_new.png https://kymos.com/de/news/prolytic-und-aeterna-zentaris-20-jahre-gemeinsame-arbeit-zur-verbesserung-der-menschlichen-gesundheit/ 2025-12-03T18:02:21+00:00 https://kymos.com/wp-content/uploads/2022/03/2022-03-24Banner-ChromV3_small.png https://kymos.com/fr/news/prolytic-et-aeterna-zentaris-20-ans-damelioration-de-la-sante-humaine-ensemble/ 2025-12-03T18:02:21+00:00 https://kymos.com/wp-content/uploads/2022/03/2022-03-24Banner-ChromV3_small.png https://kymos.com/ko/news/%eb%aa%a8%eb%93%a0-%ec%a0%9c%ed%98%95%ec%97%90-%eb%8c%80%ed%95%9c-%ec%9a%a9%ed%95%b4-%ed%85%8c%ec%8a%a4%ed%8a%b8/ 2025-12-03T18:02:21+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-12-Dissolution-USP-4-CE7smart_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/Dosage-forms_new.png https://kymos.com/it/news/test-di-dissoluzione-per-tutte-le-forme-di-dosaggio/ 2025-12-03T18:02:22+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-12-Dissolution-USP-4-CE7smart_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/Dosage-forms_new.png https://kymos.com/de/news/aufloesungspruefung-fuer-alle-darreichungsformen/ 2025-12-03T18:02:22+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-12-Dissolution-USP-4-CE7smart_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/Dosage-forms_new.png https://kymos.com/ko/news/pharmaprogress-%eb%b0%9d%ec%9d%80-%eb%b9%9b%ec%9d%b4-%ec%a7%80%ed%8f%89%ec%84%a0%ec%97%90-%eb%b3%b4%ec%9e%85%eb%8b%88%eb%8b%a4/ 2025-12-03T18:02:23+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-28-PHP-Newsletter_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/New-Building-V2-400x243.png https://kymos.com/it/news/pharmaprogress-luci-brillanti-allorizzonte/ 2025-12-03T18:02:23+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-28-PHP-Newsletter_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/New-Building-V2-400x243.png https://kymos.com/de/news/pharmaprogress-helle-lichter-am-horizont/ 2025-12-03T18:02:24+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-28-PHP-Newsletter_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/New-Building-V2-400x243.png https://kymos.com/fr/news/pharmaprogress-des-lueurs-despoir-se-profilent-a-lhorizon/ 2025-12-03T18:02:24+00:00 https://kymos.com/wp-content/uploads/2022/05/2022-05-28-PHP-Newsletter_Banner_small.png https://kymos.com/wp-content/uploads/2022/05/New-Building-V2-400x243.png https://kymos.com/ko/news/%ec%9c%a0%eb%9f%bd%ec%9d%98-%ec%83%9d%eb%ac%bc%ed%95%99%ec%a0%81-%eb%8f%99%eb%93%b1%ec%84%b1-%ec%97%b0%ea%b5%ac/ 2025-12-03T18:02:41+00:00 https://kymos.com/wp-content/uploads/2022/06/2022-06-22-Bioequivalence_Banner_small.png https://kymos.com/wp-content/uploads/2021/10/KYMOS-TEAM_DEPT_BIOAN_211007-BCN-1107-scaled.jpg https://kymos.com/it/news/studi-di-bioequivalenza-in-europa/ 2025-12-03T18:02:41+00:00 https://kymos.com/wp-content/uploads/2022/06/2022-06-22-Bioequivalence_Banner_small.png https://kymos.com/wp-content/uploads/2021/10/KYMOS-TEAM_DEPT_BIOAN_211007-BCN-1107-scaled.jpg https://kymos.com/de/news/bioaequivalenzstudien-in-europa/ 2025-12-03T18:02:41+00:00 https://kymos.com/wp-content/uploads/2022/06/2022-06-22-Bioequivalence_Banner_small.png https://kymos.com/wp-content/uploads/2021/10/KYMOS-TEAM_DEPT_BIOAN_211007-BCN-1107-scaled.jpg https://kymos.com/fr/news/etudes-de-bioequivalence-en-europe/ 2025-12-03T18:02:41+00:00 https://kymos.com/wp-content/uploads/2022/06/2022-06-22-Bioequivalence_Banner_small.png https://kymos.com/wp-content/uploads/2021/10/KYMOS-TEAM_DEPT_BIOAN_211007-BCN-1107-scaled.jpg https://kymos.com/ko/news/%ec%98%ac%eb%a6%ac%ea%b3%a0%eb%89%b4%ed%81%b4%eb%a0%88%ec%98%a4%ed%8b%b0%eb%93%9c-%ec%b9%98%eb%a3%8c%ec%a0%9c%ec%97%90-%eb%8c%80%ed%95%9c-%ec%83%88%eb%a1%9c%ec%9a%b4-fda-%ec%a7%80%ec%b9%a8/ 2025-12-03T18:04:25+00:00 https://kymos.com/wp-content/uploads/2024/11/header_new_fda_oligos_article.png https://kymos.com/it/news/nuove-linee-guida-della-fda-per-la-terapia-oligonucleotidica/ 2025-12-03T18:04:25+00:00 https://kymos.com/wp-content/uploads/2024/11/header_new_fda_oligos_article.png https://kymos.com/de/news/neue-fda-richtlinie-fuer-oligonukleotid-therapeutika/ 2025-12-03T18:04:25+00:00 https://kymos.com/wp-content/uploads/2024/11/header_new_fda_oligos_article.png https://kymos.com/fr/news/nouvelle-directive-de-la-fda-concernant-les-therapies-oligonucleotidiques/ 2025-12-03T18:04:26+00:00 https://kymos.com/wp-content/uploads/2024/11/header_new_fda_oligos_article.png https://kymos.com/ko/news/%eb%8d%b0%eb%85%b8%ec%88%98%eb%a7%99-%eb%b0%94%ec%9d%b4%ec%98%a4%ec%8b%9c%eb%b0%80%eb%9f%ac-rankl-%ec%96%b5%ec%a0%9c%ec%a0%9c-%ec%95%bd%eb%ac%bc-%ea%b0%9c%eb%b0%9c-%ea%b0%80%ec%86%8d%ed%99%94/ 2025-12-03T18:04:26+00:00 https://kymos.com/it/news/biosimilari-del-denosumab-accelerare-lo-sviluppo-di-farmaci-per-gli-inibitori-del-rankl/ 2025-12-03T18:04:26+00:00 https://kymos.com/de/news/denosumab-biosimilars-beschleunigung-der-arzneimittelentwicklung-fuer-rankl-inhibitoren/ 2025-12-03T18:04:26+00:00 https://kymos.com/fr/news/tests-dendotoxines-une-approche-complete-chez-kymos-group/ 2025-12-03T18:04:46+00:00 https://kymos.com/wp-content/uploads/2025/04/Endotoxin-Testing-Article-Blog-Header.webp https://kymos.com/fr/news/biosimilaires-du-denosumab-accelerer-le-developpement-de-medicaments-inhibiteurs-de-rankl/ 2025-12-03T18:04:47+00:00 https://kymos.com/wp-content/uploads/2025/01/Denosumab-Biosimilars-Article-Header-1.png https://kymos.com/ko/news/%ec%9a%a9%ed%95%b4-%ed%85%8c%ec%8a%a4%ed%8a%b8-%ec%9a%a9%ed%95%b4-%ed%85%8c%ec%8a%a4%ed%8a%b8%eb%9e%80-%eb%ac%b4%ec%97%87%ec%9d%b4%ea%b3%a0-%ec%96%b4%eb%96%bb%ea%b2%8c-%ec%a7%84%ed%96%89%ed%95%98/ 2025-12-03T18:04:47+00:00 https://kymos.com/wp-content/uploads/2025/06/Dissolution-Testing-Article-Blog-Header.png https://kymos.com/it/news/test-di-dissoluzione-cose-come-lo-eseguiamo-e-perche-e-importante/ 2025-12-03T18:04:47+00:00 https://kymos.com/wp-content/uploads/2025/06/Dissolution-Testing-Article-Blog-Header.png https://kymos.com/ko/news/%eb%82%b4%eb%8f%85%ec%86%8c-%ea%b2%80%ec%82%ac-kymos-group%ec%9d%98-%ec%99%84%eb%b2%bd%ed%95%9c-%ec%a0%91%ea%b7%bc-%eb%b0%a9%ec%8b%9d/ 2025-12-03T18:04:47+00:00 https://kymos.com/de/news/aufloesungspruefung-was-sie-ist-wie-wir-sie-durchfuehren-und-warum-sie-wichtig-ist/ 2025-12-03T18:04:47+00:00 https://kymos.com/wp-content/uploads/2025/06/Dissolution-Testing-Article-Blog-Header.png https://kymos.com/it/news/test-delle-endotossine-un-approccio-completo-presso-kymos-group/ 2025-12-03T18:04:48+00:00 https://kymos.com/fr/news/tests-de-dissolution-definition-methode-et-importance/ 2025-12-03T18:04:48+00:00 https://kymos.com/wp-content/uploads/2025/06/Dissolution-Testing-Article-Blog-Header.png https://kymos.com/de/news/endotoxin-testung-ein-umfassender-ansatz-bei-der-kymos-group/ 2025-12-03T18:04:48+00:00 https://kymos.com/ca/news/analisi-anticossos-neutralitzants/ 2025-12-03T18:05:13+00:00 https://kymos.com/wp-content/uploads/2025/09/Neutralizing-Antibodies-Main-Image.png https://kymos.com/ko/news/oligoxplorer-%ec%98%ac%eb%a6%ac%ea%b3%a0%eb%89%b4%ed%81%b4%eb%a0%88%ec%98%a4%ed%8b%b0%eb%93%9c-%ec%b9%98%eb%a3%8c%ec%a0%9c%eb%a5%bc-%ec%9c%84%ed%95%9c-cmc-%ed%94%8c%eb%9e%ab%ed%8f%bc/ 2025-12-03T18:05:14+00:00 https://kymos.com/wp-content/uploads/2025/10/Header-Blog-OligoXplorer-Article.png https://kymos.com/it/news/oligoxplorer-la-nostra-piattaforma-cmc-per-la-terapia-oligonucleotidica/ 2025-12-03T18:05:14+00:00 https://kymos.com/wp-content/uploads/2025/10/Header-Blog-OligoXplorer-Article.png https://kymos.com/ko/news/%ec%a4%91%ed%99%94-%ed%95%ad%ec%b2%b4-%ec%83%9d%eb%ac%bc%ed%95%99-%ec%a0%9c%ec%a0%9c%ec%97%90-%eb%8c%80%ed%95%9c-%ed%85%8c%ec%8a%a4%ed%8a%b8-%ec%a7%80%ec%b9%a8-%eb%b0%8f-%ec%98%81%ed%96%a5/ 2025-12-03T18:05:15+00:00 https://kymos.com/wp-content/uploads/2025/09/Neutralizing-Antibodies-Main-Image.png https://kymos.com/de/news/oligoxplorer-unsere-cmc-plattform-fuer-oligonukleotid-therapeutika/ 2025-12-03T18:05:15+00:00 https://kymos.com/wp-content/uploads/2025/10/Header-Blog-OligoXplorer-Article.png https://kymos.com/fr/news/oligoxplorer-notre-plateforme-cmc-pour-les-therapies-oligonucleotidiques/ 2025-12-03T18:05:15+00:00 https://kymos.com/wp-content/uploads/2025/10/Header-Blog-OligoXplorer-Article.png https://kymos.com/ko/news/%eb%b0%94%ec%9d%b4%ec%98%a4%ec%8b%9c%eb%b0%80%eb%9f%ac-%ea%b0%9c%eb%b0%9c-3%ec%83%81%eb%b6%80%ed%84%b0-%eb%b6%84%ec%84%9d-%eb%b9%84%ea%b5%90%ec%84%b1-%eb%b0%8f-pk-pd%ea%b9%8c%ec%a7%80/ 2025-12-03T18:05:15+00:00 https://kymos.com/wp-content/uploads/2025/11/Biosimilar-Development-Article-Header.png https://kymos.com/it/news/anticorpi-neutralizzanti-test-linee-guida-e-impatto-sui-farmaci-biologici/ 2025-12-03T18:05:16+00:00 https://kymos.com/wp-content/uploads/2025/09/Neutralizing-Antibodies-Main-Image.png https://kymos.com/de/news/neutralisierende-antikoerper-testverfahren-richtlinien-und-auswirkungen-auf-biologika/ 2025-12-03T18:05:16+00:00 https://kymos.com/wp-content/uploads/2025/09/Neutralizing-Antibodies-Main-Image.png https://kymos.com/fr/news/anticorps-neutralisants-tests-lignes-directrices-et-impact-sur-les-produits-biologiques/ 2025-12-03T18:05:16+00:00 https://kymos.com/wp-content/uploads/2025/09/Neutralizing-Antibodies-Main-Image.png https://kymos.com/it/news/sviluppo-di-farmaci-biosimilari-dalla-fase-iii-alla-comparabilita-analitica-e-alla-farmacocinetica-farmacodinamica/ 2025-12-03T18:05:25+00:00 https://kymos.com/wp-content/uploads/2025/11/Biosimilar-Development-Article-Header.png https://kymos.com/de/news/biosimilar-entwicklung-von-phase-iii-zur-analytischen-vergleichbarkeit-und-pk-pd/ 2025-12-03T18:05:26+00:00 https://kymos.com/wp-content/uploads/2025/11/Biosimilar-Development-Article-Header.png https://kymos.com/fr/news/developpement-des-biosimilaires-de-la-phase-iii-a-la-comparabilite-analytique-et-a-la-pharmacocinetique-pharmacodynamique/ 2025-12-03T18:05:26+00:00 https://kymos.com/wp-content/uploads/2025/11/Biosimilar-Development-Article-Header.png https://kymos.com/fr/news/usp-substances-extractibles-et-lixiviables-dans-les-systemes-a-usage-unique/ 2026-01-22T09:11:54+00:00 https://kymos.com/wp-content/uploads/2026/01/EL-USP-665-Blog-Article-Image.png https://kymos.com/de/news/usp-extrahierbare-und-auslaugbare-stoffe-in-einwegsystemen/ 2026-01-22T09:11:54+00:00 https://kymos.com/wp-content/uploads/2026/01/EL-USP-665-Blog-Article-Image.png https://kymos.com/it/news/usp-sostanze-estraibili-e-rilasciabili-nei-sistemi-monouso/ 2026-01-22T09:11:54+00:00 https://kymos.com/wp-content/uploads/2026/01/EL-USP-665-Blog-Article-Image.png https://kymos.com/es/news/usp-extraibles-y-lixiviables-en-sistemas-de-un-solo-uso/ 2026-01-22T09:11:54+00:00 https://kymos.com/wp-content/uploads/2026/01/EL-USP-665-Blog-Article-Image.png https://kymos.com/ko/news/%eb%af%b8%ea%b5%ad-%ed%8a%b9%ed%97%88-%ec%9d%bc%ed%9a%8c%ec%9a%a9-%ec%8b%9c%ec%8a%a4%ed%85%9c%ec%9d%98-%ec%b6%94%ec%b6%9c%eb%ac%bc-%eb%b0%8f-%ec%9a%a9%ec%b6%9c%eb%ac%bc/ 2026-01-22T09:11:54+00:00 https://kymos.com/wp-content/uploads/2026/01/EL-USP-665-Blog-Article-Image.png https://kymos.com/news/usp665-extractables-leachables-in-single-use-systems/ 2026-01-22T09:16:48+00:00 https://kymos.com/wp-content/uploads/2026/01/EL-USP-665-Blog-Article-Image.png https://kymos.com/ca/news/usp-materials-extraibles-i-lixiviables-en-sistemes-d39un-sol-us/ 2026-01-22T10:47:38+00:00 https://kymos.com/wp-content/uploads/2026/01/EL-USP-665-Blog-Article-Image.png https://kymos.com/es/news/liraglutida-y-semaglutida-analisis-de-estudios-biosimilares-para-agonistas-del-receptor-glp-1/ 2026-01-22T14:40:32+00:00 https://kymos.com/wp-content/uploads/2024/02/2024-20-02-LiraglutideSemaglutide.png https://kymos.com/ca/news/liraglutida-i-semaglutida-explorant-estudis-biosimilars-per-a-agonistes-del-receptor-glp-1/ 2026-01-22T14:40:35+00:00 https://kymos.com/wp-content/uploads/2024/02/2024-20-02-LiraglutideSemaglutide.png https://kymos.com/ca/news/biosimilars-de-denosumab-accelerant-el-desenvolupament-de-farmacs-per-a-inhibidors-de-rankl/ 2026-01-22T14:40:55+00:00 https://kymos.com/wp-content/uploads/2025/01/Denosumab-Biosimilars-Article-Header-1.png https://kymos.com/es/news/biosimilares-de-denosumab-aceleracion-del-desarrollo-de-farmacos-para-inhibidores-de-rankl/ 2026-01-22T14:40:55+00:00 https://kymos.com/wp-content/uploads/2025/01/Denosumab-Biosimilars-Article-Header-1.png https://kymos.com/it/news/kymos-group-festeggia-25-anni-sostenerelascienza/ 2026-02-09T10:33:52+00:00 https://kymos.com/wp-content/uploads/2026/02/F1_v5_Post-Marca-25-anos.jpg https://kymos.com/fr/news/kymos-group-celebre-ses-25-ans-supportingscience/ 2026-02-09T10:33:52+00:00 https://kymos.com/wp-content/uploads/2026/02/F1_v5_Post-Marca-25-anos.jpg https://kymos.com/de/news/die-kymos-group-feiert-25-jahre-supportingscience/ 2026-02-09T10:33:52+00:00 https://kymos.com/wp-content/uploads/2026/02/F1_v5_Post-Marca-25-anos.jpg https://kymos.com/ca/news/kymos-group-celebra-25-anys-supportingscience/ 2026-02-09T10:33:52+00:00 https://kymos.com/wp-content/uploads/2026/02/F1_v5_Post-Marca-25-anos.jpg https://kymos.com/es/news/kymos-group-celebra-25-anos-supportingscience/ 2026-02-09T10:33:52+00:00 https://kymos.com/wp-content/uploads/2026/02/F1_v5_Post-Marca-25-anos.jpg https://kymos.com/ko/news/kymos-group-25%ec%a3%bc%eb%85%84-%ea%b8%b0%eb%85%90-supportingscience/ 2026-02-09T10:33:52+00:00 https://kymos.com/wp-content/uploads/2026/02/F1_v5_Post-Marca-25-anos.jpg https://kymos.com/news/25-years-anniversary/ 2026-02-09T10:37:46+00:00 https://kymos.com/wp-content/uploads/2026/02/F1_v5_Post-Marca-25-anos.jpg https://kymos.com/es/news/kymos-group-acquires-particle-analytical/ 2026-02-27T08:00:18+00:00 https://kymos.com/wp-content/uploads/2026/02/IMG_Blog_KYMOSPARTICLE-scaled.jpg https://kymos.com/it/news/kymos-group-si-espande-con-lacquisizione-di-particle-analytical/ 2026-02-27T09:00:18+00:00 https://kymos.com/wp-content/uploads/2026/02/IMG_Blog_KYMOSPARTICLE-scaled.jpg https://kymos.com/ko/news/kymos-group-particle-analytical-%ec%9d%b8%ec%88%98%eb%a1%9c-%ec%82%ac%ec%97%85-%ed%99%95%ec%9e%a5/ 2026-02-27T09:00:18+00:00 https://kymos.com/wp-content/uploads/2026/02/IMG_Blog_KYMOSPARTICLE-scaled.jpg https://kymos.com/de/news/kymos-group-expandiert-durch-die-uebernahme-von-particle-analytical/ 2026-02-27T09:00:18+00:00 https://kymos.com/wp-content/uploads/2026/02/IMG_Blog_KYMOSPARTICLE-scaled.jpg https://kymos.com/fr/news/kymos-group-sagrandit-avec-lacquisition-de-particle-analytical/ 2026-02-27T09:00:18+00:00 https://kymos.com/wp-content/uploads/2026/02/IMG_Blog_KYMOSPARTICLE-scaled.jpg https://kymos.com/news/kymos-and-prolytic-merge-to-become-kymos-group/ 2026-03-04T20:08:45+00:00 https://kymos.com/wp-content/uploads/2021/11/2020-09-28-Kymos-and-Prolytic-merge_srt-e1658232445349.png https://kymos.com/fr/news/kymos-et-prolytic-fusionnent-pour-former-le-groupe-kymos/ 2026-03-04T20:10:26+00:00 https://kymos.com/wp-content/uploads/2021/11/2020-09-28-Kymos-and-Prolytic-merge_srt-e1658232445349.png https://kymos.com/ko/news/kymos%ec%99%80-prolytic%ec%9d%b4-%ed%95%a9%eb%b3%91%ed%95%98%ec%97%ac-kymos-group%ec%9d%b4-%eb%90%98%ec%97%88%ec%8a%b5%eb%8b%88%eb%8b%a4/ 2026-03-04T20:10:26+00:00 https://kymos.com/wp-content/uploads/2021/11/2020-09-28-Kymos-and-Prolytic-merge_srt-e1658232445349.png https://kymos.com/ca/news/kymos-i-prolytic-es-fusionen-per-convertir-se-en-kymos-group/ 2026-03-04T20:10:26+00:00 https://kymos.com/wp-content/uploads/2021/11/2020-09-28-Kymos-and-Prolytic-merge_srt-e1658232445349.png https://kymos.com/de/news/kymos-und-prolytic-fusionieren-zur-kymos-group/ 2026-03-04T20:10:52+00:00 https://kymos.com/wp-content/uploads/2021/11/2020-09-28-Kymos-and-Prolytic-merge_srt-e1658232445349.png https://kymos.com/it/news/kymos-e-prolytic-si-fondono-per-diventare-kymos-group/ 2026-03-04T20:11:12+00:00 https://kymos.com/wp-content/uploads/2021/11/2020-09-28-Kymos-and-Prolytic-merge_srt-e1658232445349.png https://kymos.com/es/news/kymos-y-prolytic-se-fusionan-para-convertirse-en-kymos-group/ 2026-03-04T20:11:12+00:00 https://kymos.com/wp-content/uploads/2021/11/2020-09-28-Kymos-and-Prolytic-merge_srt-e1658232445349.png https://kymos.com/it/news/i-tuoi-studi-di-stabilita-in-mani-sicure/ 2026-03-05T06:42:40+00:00 https://kymos.com/wp-content/uploads/2021/04/Stability-Newsletter_fitted-e1658237143331.png https://kymos.com/news/kymos-group-acquires-particle-analytical/ 2026-03-17T14:38:56+00:00 https://kymos.com/wp-content/uploads/2026/02/IMG_Blog_KYMOSPARTICLE-scaled.jpg https://kymos.com/news/biosimilar-development-change/ 2026-03-17T14:48:27+00:00 https://kymos.com/wp-content/uploads/2025/11/Biosimilar-Development-Article-Header.png https://kymos.com/news/oligoxplorer/ 2026-03-17T14:51:18+00:00 https://kymos.com/wp-content/uploads/2025/10/Header-Blog-OligoXplorer-Article.png https://kymos.com/news/what-is-dissolution-testing/ 2026-03-17T14:53:39+00:00 https://kymos.com/wp-content/uploads/2025/06/Dissolution-Testing-Article-Blog-Header.png https://kymos.com/ca/news/kymos-group-sexpandeix-amb-ladquisicio-de-particle-analytical/ 2026-03-17T15:12:57+00:00 https://kymos.com/wp-content/uploads/2026/02/IMG_Blog_KYMOSPARTICLE-scaled.jpg https://kymos.com/news/one-stop-solution/ 2026-03-19T12:32:14+00:00 https://kymos.com/wp-content/uploads/2026/03/One-Stop-Solutions-Blog-Article-Header.png https://kymos.com/es/news/usp-extraibles-y-lixiviables-en-sistemas-de-un-solo-uso-2/ 2026-03-19T12:46:36+00:00 https://kymos.com/wp-content/uploads/2026/03/One-Stop-Solutions-Blog-Article-Header.png https://kymos.com/it/news/usp-sostanze-estraibili-e-rilasciabili-nei-sistemi-monouso-2/ 2026-03-19T12:47:14+00:00 https://kymos.com/wp-content/uploads/2026/03/One-Stop-Solutions-Blog-Article-Header.png https://kymos.com/fr/news/usp-substances-extractibles-et-lixiviables-dans-les-systemes-a-usage-unique-2/ 2026-03-19T12:47:28+00:00 https://kymos.com/wp-content/uploads/2026/03/One-Stop-Solutions-Blog-Article-Header.png https://kymos.com/ca/news/usp-materials-extraibles-i-lixiviables-en-sistemes-dun-sol-us/ 2026-03-19T12:48:01+00:00 https://kymos.com/wp-content/uploads/2026/03/One-Stop-Solutions-Blog-Article-Header.png https://kymos.com/ko/news/%eb%af%b8%ea%b5%ad-%ed%8a%b9%ed%97%88-%ec%9d%bc%ed%9a%8c%ec%9a%a9-%ec%8b%9c%ec%8a%a4%ed%85%9c%ec%9d%98-%ec%b6%94%ec%b6%9c%eb%ac%bc-%eb%b0%8f-%ec%9a%a9%ec%b6%9c%eb%ac%bc-2/ 2026-03-19T12:48:47+00:00 https://kymos.com/wp-content/uploads/2026/03/One-Stop-Solutions-Blog-Article-Header.png https://kymos.com/de/news/usp-extrahierbare-und-auslaugbare-stoffe-in-einwegsystemen-2/ 2026-03-19T12:49:15+00:00 https://kymos.com/wp-content/uploads/2026/03/One-Stop-Solutions-Blog-Article-Header.png